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Heart disease is a major cause of death worldwide. As a result of 
myocardial infarction, functional cardiomyocytes are lost and this 
results in a heart that does not contract properly. The pig model is a 
good model to study cardiac functions in humans, as the size of the 
heart in the pig is similar to that of the human. In this project, we 
aim to convert porcine fibroblast cells into porcine cardiomyocytes, 
in the hope of creating new functional cardiomyocytes to replace 
the ones that are no longer functional after myocardial infarction.  
 
As no porcine embryonic stem cells have been isolated, induced 
pluripotent stem cells for the pig must be used as a source of 
pluripotent cells. Hence, fibroblasts from the pig is taken, and 
induced into pluripotent cells. These cells are in turn differentiated 
into cardiomyocytes, where more downstream work can be done to 
characterize them and also to use these cells as form of therapy for 
the failing heart. 
 
In this project, we isolated fibroblasts from the pig’s thigh region, 
and used lentiviruses to induce the cells to pluripotent cells. These 
pluripotent cells are studied and characterized. The pluripotent stem 
cells exhibited morphology and genomic markers of pluripotency. 
These cells were also finally differentiated into cardiomyocytes. 
Even though the differentiated cells did not beat, there were cardiac 
genes found to be expressed in the form of mRNA. This shows that 
the differentiation protocol is successful to a certain extent. More 
work can be done to streamline to protocol to achieve greater 
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Heart disease is a major cause of death worldwide. In the United 
States, 1.25 million people suffer from myocardial infarction each 
year (Roger et al., 2011). Such conditions result in the loss of 
functional cardiomyocytes in the heart and fibroblasts take the place 
of cardiomyocytes in the form of scar tissue. This results in a heart 
that is no longer able to contract properly. Such replacement of 
cardiomyocytes with fibroblastic scar tissue shows that the heart is 
unable to regenerate to replace lost cardiomyocytes due to injury. 
After birth, cardiomyocytes are not able to go into cell cycle 
(Pasumarthi & Field, 2002) for cell growth and renewal. 
Consistently, Carbon dating has shown that cardiomyocytes in the 
adult human heart has a renewal ability of less than 1% each year 
(Bergmann et al., 2009). Currently, orthotropic heart transplantation 
remains the only viable option for advanced heart failure patients. 
However, there is a chronic lack of donor organs. Hence, it is 
important to ensure that the cardiomyocytes lost from heart failure 












2. Aims and objectives 
To repair the damaged heart, it is imperative to replace lost 
cardiomyocytes that will maintain its function. Hence, we attempt to 
generate porcine induced pluripotent stem cells (IPSCs) from 
porcine fibroblast cells and differentiate such cells into cardiac 
lineages to provide a model to study the development of cardiac 




















3. Literature Review 
3.1 Human Embryonic Stem Cells (hESCs) 
Human Embryonic Stem Cells are pluripotent cells derived from 
the inner cell mass of the developing blastocyst (Evans & 
Kaufman, 1981;Thomson et al., 1998). Such cells can be 
cultured in vitro and are able to remain stable both karyotypically 
as well as phenotypically (Amit et al., 2000). Such cells are also 
able to be propagated in vitro in an undifferentiated state 
(Reubinoff, Pera, Fong, Trounson, & Bongso, 2000). The ability 
to remain undifferentiated allows hESCs to have a capacity to 
generate any cell that is required in the body. hESCs are able to 
differentiate into three germ layers, endoderm, mesoderm and 
ectoderm. Such differentiation potential is shown by inducing 
differentiation of hESCs by the formation of embryoid bodies 
that composes of the three different germ layers (Itskovitz-Eldor 
et al., 2000).  
 
With the discovery of pluripotent human Embryonic Stem Cells, 
they hold the promise of generating specific types of tissues for 
the application of regenerative medicine, such as in diseases 
like Parkinson disease and diabetes mellitus (Hori et al., 2002; 
Kim et al., 2002). As most vital organs do not have the innate 
ability to regenerate, human Embryonic Stem Cells are believed 
to become imperative in this new approach as they can be 
utilized as a cellular source to replace damaged tissues.  In 
addition, human Embryonic Stem Cells can be used as a 
platform for drug discovery and toxicology as they can be used 
as biotools for the discovery of drugs that may activate the cells 
for regeneration (Ameen et al., 2008; Synnergren et al., 2008). 
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3.2 Porcine Embryonic Stem Cells 
Thus far, there have not been any conclusive porcine ESC lines 
that have been isolated. Since 1990(Notarianni, Laurie, Moor, & 
Evans, 1990), various groups have tried to isolate porcine ESC 
lines. However, well-defined porcine ESC lines were elusive. 
Porcine ESC cell lines did not survive past passage 10 when 
they were plated on homologous embryonic fibroblasts 
(Piedrahita, Anderson, & Bondurant, 1990).  
 
It is also important to note that there is no known developmental 
stage that pig IPS cells can be derived during embryonic 
development. For the case of the mouse, its blastocyst contains 
three cell types during the implantation stage, namely the 
epiblast, trophectoderm and also the primitive 
endoderm(Rossant, 2007). The epiblast cells will develop into 
the embryo and these cells will give rise to ESCs (Brook & 
Gardner, 1997). In the case of humans and rodents, such 
epiblast cells are not exposed to the uterine environment. 
However, the blastocyst of the pig has a longer period of 
development before it is being implanted. Exposure to the 
uterine environment takes places during such a period. In 
humans, the formation of three germ layers occurs 6 days after 
fertilization (Dvash & Benvenisty, 2004). In pigs, the blastocyst 
hatches at day 6 or 7, and there is no epiblast that is present in 
the blastocyst before it hatches. The epiblast formation in the pig 
only starts after hatching and completes at day 12. This epiblast 
is then exposed to the uterine region (Vejlsted, Du, Vajta, & 
Maddox-Hyttel, 2006). After which, the epiblast differentiated 
and various germ layers such as the mesoderm and the 
endoderm layers appeared (Tam & Behringer, 1997). The cells 
then show a downregulation of the gene OCT4, which codes for 
pluripotency. Hence, the embryos obtained at this stage cannot 
be used for the isolation of ESCs. Therefore, there is no known 
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optimal period during the development of the porcine embryo 
that ESC lines may be isolated, and it is unclear if porcine stem 
cells isolated from the inner cell mass or from the epiblast stage 
can be cultured and remain pluripotent in vitro. However, there 
have been reports that the use of day 7 embryos has 
advantages over the use of day 11 embryos (Wianny, Perreau, 
& Hochereau de Reviers, 1997). 
 
Mouse ESCs and human ESCs have extremely different culture 
conditions. Hence, the use of similar culture conditions and 
protocols for the isolation of porcine ESCs may not be sufficient 
for the survival and the maintenance of its pluripotency(Brevini, 
Antonini, Cillo, Crestan, & Gandolfi, 2007). 
 
3.3     Generation of Induced Pluripotent Stem Cells 
Embryonic stem cells (ESCs) hold great promises for 
regenerative medicine as they are pluripotent and are able to 
grow indefinitely (Evans & Kaufman, 1981). However, many 
ethical concerns surround the use of such cells that are derived 
from human embryos. There are several methods that IPSCs 
can be generated. This results in the limited application of ESCs. 
Also, it is not easy to generate disease specific ESCs in order to 
create a models for further studies. It is also impossible to 
generate patient specific ESCs. Hence, in order to overcome 
such issues, Yamanaka et al created the induced pluripotent 
stem cells, IPSCs, by direct reprogramming (Yamanaka, 2007). 
There are several methods to generate IPSCs. Table 3.1 below 
shows the various methods, its application and the advantages 




Table 3.1 The applications, reprogramming methods and the 
advantages of using each method for somatic cell reprogramming 
(Gonzalez, Boue, & Izpisua Belmonte, 2011) 
 
 
3.3.1 Retroviral/ Lentiviral Reprogramming 
Yamanaka et al showed that IPSCs are able to be generated 
from dermal fibroblasts by the retroviral transfection of 
transcription factors, namely Oct4, Sox2, KLF4 and c-myc. 
IPSCs generated were indistinguishable from ESCs in 
morphology, gene expression and pluripotency status.  
 
Figure 3.1 Time-line for retroviral reprogramming of human dermal 
fibroblasts (Takahashi et al., 2007) 
 
The procedure for the transfection of dermal fibroblasts is shown 
in Fig 3.1. After retroviral infection on day 0, the fibroblast cells 
were trypsinized and seeded onto mitomycin-C treated SNL 
feeder cells. After which, the media was changed to ES media 
supplemented with basic Fibroblast Growth Factor (bFGF). At 
day 30, colonies were able to be picked and they were 
mechanically dissociated into small clusters. These clusters 
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were then expanded on a fresh plate of feeder cells (Takahashi 
et al., 2007). Lentiviral reprogramming methods have also been 
used to reprogram somatic cells. There is an advantage of using 
lentiviruses to reprogram cells as lentiviruses are able to infect 
both dividing and non-dividing cells. A lentiviral system that 
allows researchers to be able to control the expression of the 
reprogramming factors has also been developed. It allows the 
study of the timeline required for reprogramming as well as the 
changes in various key molecular determinants during 
reprogramming. One additional vector has been included into 
the system. This vector constitutively expresses the ‘reverse 
tetracycline transactivator (rtTA)’. After the reprogramming 
factors as well as the rtTA vector have been introduced into the 
somatic cells, doxycycline is added. With the use of doxycycline, 
the rtTA that was introduced allow the reprogramming factors to 
be expressed. When doxycycline is not omitted, the exogenous 
transcription factors that code for pluripotency are not expressed. 
Such a system has been used to reprogram mouse fibroblasts. 
Specifically for mouse IPSCs, the addition of doxycycline was 
necessary for 8-12 days after the induction process. It was then 
shown that doxycycline was dispensable thereafter, and the 
mouse IPSCs did not require the addition of doxycycline to 
remain in a pluripotent state (Brambrink et al., 2008). Cell 
colonies that were not fully reprogrammed were unable to 
survive and were found to be differentiated with the withdrawal 
of doxycycline. This shows that the cells had not reactivated 
their endogenous self-renewal ability. This allows researchers to 
identify the colonies that were fully reprogrammed.  
 
However, the viral reprogramming uses genome-integrating 
vectors and these results in various forms of mutations (Okita, 
Ichisaka, & Yamanaka, 2007). Transgene expressions during 
differentiation could then affect the functionality of IPSCs. Such 
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integration can also direct differentiation towards certain 
lineages, or result in the formation of tumors. To avoid such 
problems, various groups tried to develop methods to generate 
IPSCs without the integration of vectors into the cell’s genome. 
One such method involves the use of episomal plasmids. 
 
3.3.2 Episomal Reprogramming 
Episomal Reprogramming uses episomal plasmids with an 
oriP/EBNA1 (Epstein-Barr nuclear antigen-1) backbone. These 
plasmids can be transfected without the need to form viruses, 
and such vectors can be easily removed from cultured cells by 
simple culturing the cells without drug selection. However, the 
reprogramming efficiency is extremely low (Yu et al., 2007). In 
order to increase the reprogramming efficiency, IRES2 (internal 
ribosomal entry site 2) was used to co-express the 
reprogramming factors. As c-myc has toxic effects to a cell, 
SV40 large T gene (SV40LT) was used to counter its effects. 
Hence, the resulting combination of genes in the episomal 
vectors includes Oct4, SOX2, c-myc, KLF4, Lin28, NANOG, and 
SV40LT. Such episomal transfection methods were successful 
in producing IPSCs with similar morphology and gene 
expression as ESCs.In order to increase the efficiency of the 
reprogramming process, small molecules could be used. This 
could decrease the loss of the episomal transgene during the 
first two weeks after the transfection. Yu et al found that the 
episomal reprogramming improved with the addition of (1) 
mitogen-activated protein kinase (MEK) kinase inhibitor, 
PD0325901, (2) glycogen synthase kinase 3 beta (GSK3b) 
inhibitor, CHIR99021 and a TGFb/Activin/Nodal receptor 
inhibitor A-83-01. Human leukemia inhibitory factor (hLIF) 
increased the proliferation of cells that were intermediates of the 
reprogramming process. Another molecule that had an effect on 
the reprogramming was ROCK inhibitor, HA-100. It was also 
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found that the addition of small molecules during the early 
stages of reprogramming, i.e. day 1 to day 5, was crucial to 
obtain the maximum impact from the addition of such small 
molecules(Yu, Chau, Vodyanik, Jiang, & Jiang, 2011).  
 
3.3.3 mRNA reprogramming 
Another method to reprogram somatic cells is to use synthetic 
messenger RNAs (Warren et al., 2010). Somatic cells are 
bombarded with mRNAs repeatedly. To lengthen the half-life of 
the RNA used, a 5’ guanine cap, as well as a poly A tail was 
added to the RNA. The mRNA is then delivered to the cell via 
electroporation. In order to increase the cell viability, the media 
was supplemented with B18R, which is a vaccinia virus decoy 
receptor for type 1 interferons (Symons, Alcami, & Smith, 1995).  
 
3.3.4 Chemical reprogramming 
In order to reduce safety issues in the use of IPSCs, several 
groups have begun to explore the possibility of generation 
IPSCs using purely chemical methods. The advantage of using 
chemical compounds is that the molecules are readily available 
to the cells, and such molecules can pass through the 
membrane of the cell, allowing for simple removal after the 
reprogramming process. Currently, mouse cells have been 
reprogrammed into IPSCs using only chemical molecules. Hou 
et al, was able to convert mouse embryonic fibroblasts (MEFs) 
into IPSCs using a cocktail of seven small molecules (Hou et al., 
2013). The small molecules used include: (1) CHIR, a glycogen 
synthase kinase 3, (2) FSK, cAMP agonist, (3)TTNPB, a retinoic 
acid receptor ligand, (4) 16452, a TGF-beta inhibitor, (5)DZNep, 
an S-adenosylhomocysteine hydrolase inhibitor, (6) 
tranylcypromine, an inhibitor of lysine-specific demethylase 1 
and (7) valporic acid, a histone deacetylase inhibitor. The 
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reprogramming process is shown in figure 3.2 below(Masuda et 
al., 2013). 
 
Figure 3.2 Schematic of the reprogramming process using chemical 
methods 
 
3.3.5 Genes that regulate pluripotency in Human 
Embryonic Stem Cells 
There are several molecular mechanisms which regulate the 
self-renewal and pluripotency of mESCs and hESCs. Compared 
to somatic stem cells where self-renewal is due to asymmetrical 
cell division, the self-renewal of ESCs results from symmetrical 
cell division, producing two identical pluripotent daughter cells.  
 
Some novel genes that are studied for maintaining pluripotency 
in human Embryonic Stem Cells are Stat3 (Niwa, Burdon, 
Chambers, & Smith, 1998), FoxD3 (Hanna, Foreman, 
Tarasenko, Kessler, & Labosky, 2002), and NANOG (Mitsui et 
al., 2003). The gene OCT4 was the first such pluripotent factor 
that was identified and it has been studied extensively over the 
past decade. (Pan, Chang, Scholer, & Pei, 2002). Studies have 
shown that the homeodomain proteins NANOG, OCT4 and Sox 
2 constitute a conserved core transcriptional network which 
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specifies ESC pluripotency in both human and mice (Avilion et 
al., 2003; Loh et al., 2006).  The small set of ‘core’ pluripotency 
factors for hESC are described in the following sections.  
 
3.3.6 OCT4 
OCT4 is a homeodomain transcription factor of the POU (Pit Oct 
Unc) family. Such homeodomain transcription factors are 
conserved in evolution and have crucial roles in determining the 
fate of cells in many organisms (Hombria & Lovegrove, 2003). 
This protein is extremely important in the self-renewal of 
embryonic stem cells in the pluripotent stage. As such, it is used 
as a marker in the selection of undifferentiated cells. However, 
OCT4 expression must be regulated carefully; too much 
expression or too little expression will result in the differentiation 
of the pluripotent cells. An increase in the expression of OCT4 in 
Embryonic Stem cells results in a phenotype that has results 
which is similar to the loss of NANOG function (Chambers et al., 
2003) while the decreased in the expression of OCT4 causes 
cell differentiation (Niwa, Miyazaki, & Smith, 2000). In both 
human and murine Embryonic Stem Cells, OCT4 is known to 
interact with other transcription factors to regulate gene 
expression (Hay, Sutherland, Clark, & Burdon, 2004; Pesce & 
Scholer, 2001). OCT4 has long been understood to be essential 
for early development and maintenance of pluripotency in cells 
(Nichols et al., 1998). 
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3.3.7 SOX2 
Sox family proteins arise from a group of genes related to the 
mammalian testis-determining factor Sry (Sinclair et al., 1990). 
Sox proteins have highly conserved high mobility group (HMG) 
domains that are made up of 79 amino acids and are involved in 
DNA recognition and binding (Harley, Lovell-Badge, & 
Goodfellow, 1994).  Sox proteins play important roles in the 
differentiation and development of cells(Pevny & Lovell-Badge, 
1997). Sox2 is expressed in the pluripotent lineage of the mouse 
embryo, and it is also expressed in the multipotent cells of the 
ectoderm layer in the extraembryonic regions and also in the 
precursor cells of the developing central nervous system. This 
shows that Sox2 has a role in the preservation of developmental 
potential. Also, embryos without Sox2 fail to form Embryonic 




Nanog Is a homeobox-containing transcription factor with an N-
terminal serine rich 96 amino acid sequence and a C-terminal 
region of 150 amino acids. The transactivating potential of the 
human NANOG protein appears to be conserved in the C-
terminal region but not in the N-terminal region. The C-terminus 
has a high amount of tryptophan repeats which are crucial to 
NANOG’s role in maintaining the self-renewal abilities of stem-
cells.  Hence, NANOG is essential for the maintenance of 
human Embryonic Stem Cells in vitro. The mRNA of NANOG is 
only present in undifferentiated and pluripotent mouse and 
human cell lines (Chambers et al., 2003). The expression of 
NANOG is significantly downregulated in differentiated cells. The 
overexpression of NANOG would allow the pluripotency and 
self-renewing characteristics of ESCs to be maintained under 
what normally would be differentiation-inducing culture 
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conditions (Chambers et al., 2003).  Also, NANOG knockdown 
experiments in mouse Embryonic Stem Cells resulted in a loss 
of their self-renewal properties together with an increased 
propensity for differentiation (Mitsui et al., 2003). Also, it is 
shown that the ablation of NANOG in vivo causes a failure in the 
specification of early embryo pluripotent cells, which adopt a 
differentiated visceral endodermal fate (Mitsui et al., 2003).  This 
shows the importance of the role of NANOG in maintaining 
pluripotency in Embryonic Stem Cells. NANOG has taken 
centre-stage among a novel group of genes which regulate 
pluripotency and self-renewal in the embryo (Ramalho-Santos, 
Yoon, Matsuzaki, Mulligan, & Melton, 2002).  In the blastocyst 
stage of the developing embryo, the expression level of NANOG 
is high, but significantly downregulated and even becomes 
undetectable in adult tissues (Chambers et al., 2003). 
 
3.3.9 KLF4 
Krϋppel-like factors (KLFs) are named after the Drosophila 
embryonic pattern regulator Krϋppel, and their DNA-binding 
domains shows much similarity. The distinguishing factor of the 
KLF family is the presence of three highly conserved classical 
zinc fingers. KLF4 was isolated from the gastrointestinal tract 
and is highly expressed in the post-mitotic cells of both the gut 
and the skin epithelium (Dang, Pevsner, & Yang, 2000). KLF4 
has been identified as one of the factors that can induce somatic 
cells into a pluripotent Embryonic Stem Cell-like state, through 
the retroviral transduction of murine fibroblasts (Meissner, 
Wernig, & Jaenisch, 2007). The KLF1, 2 and 4 transcription 
factors is more closely related to one another than the other 
factors of the KLF family. Studies have shown that they regulate 
the transcription process in many types of  cellular processes 




c-myc is located on chromosome 8 in the human genome. It has 
been observed that IPSCs can be generated without the use of 
c-myc. The use of c-myc in the reprogramming process has 
been reported to be not essential and having several negative 
effects (Nakagawa et al., 2008). For example, c-myc, being an 
oncogene, has led to the formation of cancers when the gene is 
reactivated in the IPSCs. However, using chromatin precipitation, 
it has been shown that the role of c-myc in the maintenance of 
pluripotencyis significant, as C-myc regulates several genes 
downstream (Lin, Jackson, Guo, Linsley, & Eisenman, 2009). C-
myc is also involved in histone acetylation, especially in the 
regulation of the histone acetylation transferase complex (Doyon 
& Cote, 2004).  
 
3.3.11 Lin28 
Lin28 codes for a microRNA-binding protein that binds to IGF-2 
(insulin-like factor 2) mRNA. It is expressed in ESCs and is used 
to increase the efficiency of the reprograming process (Yu et al., 
2007). Lin28 was also found to significantly increase the number 
of IPSC colonies formed when fibroblasts were transduced with 
Oct4, SOX2, KLF4 and c-myc. LIN28 is also able toenhance the 
maturation of the reprogrammed cells by accelerating the 
proliferation of IPSCs that were TRA-1-60 positive. Hence, this 
shows the function of LIN28 in the reprogramming 






3.4 Cardiac differentiation of Human IPS cell lines 
With the discovery of IPS technology, we are able to use a 
patient’s own somatic cells and turn it into stem cells which can 
be propagated indefinitely. Hence, through IPSCs we are also 
able to obtain a constant supply of patient specific 
cardiomyocytes for cell therapy, drug screening as well as  
models for the study of various genetic diseases such as 
Mendelian arrhythmia syndromes. Here, several cardiac 
differentiation methods to obtain human cardiomyocytes will be 
described.  
 
From literature, ESCs and IPSCs were grown on MEFs and they 
were dispersed by the addition of collagenase I, and transferred 
to a low attachment dish where they were cultured in 
suspension to form embryoid bodies (EBs). The EBs were then 
transferred on gelatin coated plates, and attached on the culture 
surface. After 4 days, spontaneous beating was observed 
(Kehat et al., 2001). Small molecular inhibitors such as 
SB203580, a p38 MAPK inhibitor have also been used to 
generate cardiomyocytes from IPS cells (Graichen et al., 2008). 
At concentrations of less than 10uM, it was able to direct 
differentiation of stem cells towards the cardiac lineage. Growth 
factors such as BMP4 and Activin A have also been used to 
direct the differentiation of IPS cell lines into cardiomyocytes. 
However, it is important to note that the timing which the growth 
factors are added is crucial in ensuring the differentiation 
efficiency. For some growth factors such as Wnts, it is 
necessary to increase its expression during the early stage of 
differentiation, but to inhibit such signalling during the later stage 
of differentiation.  
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Monolayer differentiation can also be performed (Laflamme et 
al., 2007). IPS cells can be seeded on Matrigel™, and the media 
was replaced to RPMI-B27 medium with Activin A. After 24 
hours, the media was changed to RMPI-B27 with BMP4 for the 
next 4 days. The media was then changed to RPMI-B27 without 
any growth factors. Beating areas were observed about 12 days 
after the differentiation process was started.  
 
Co-culture protocols were also developed to differentiate IPS 
cells into cardiomyocytes (Mummery et al., 2003). END-2, a 
mouse visceral endoderm-like cell line was co-cultured with IPS 
cells. Beating regions were observed after 12 days. The use of 
media without serum and insulin increases the efficiency of 
cardiomyocytes differentiation by 10 fold.  
 
With the ability to generate cardiomyocytes from IPS cell lines, 
there are several factors to consider before the use of 
cardiomyocytes for cell therapy (Odorico, Kaufman, & Thomson, 
2001). The cardiomyocytes must be pure, and no parental stem 
cells should be used as stem cells are oncogenic and will result 
in the formation of tumours. Various cardiomyocytes lineages 
must be isolated. For example, atrial, ventricular and nodal cells 
must be separated. It is also important that the cardiomyocytes 
are able to have a normal physiological profile. Such cells must 
also be able to retain their function as well as their viability after 
transplant. Such transplanted cells must also not be rejected by 
the patient. It is important to resolve such issues before 





3.5 Generation of Porcine Induced Pluripotent Stem 
Cells 
The pig is a good model to use for the study of heart disease 
and regenerative medicine. The physiology of the pig is 
extremely similar to humans, and this allows us to use them to 
explore genetic therapy, cell therapy and other types of 
regenerative medicine. Currently, porcine heart valves are used 
to replace damaged heart valves in a human (Hilbert & Ferrans, 
1992). Thus far, there has been little success in the 
development of porcine ESCs except for the generation of LIF-
dependent pluripotent stem cells (Telugu et al., 2011), as well as 
porcine epiblast stem cells (Rodriguez, Contreras, & Alberio, 
2013). Hence, it has been suggested that the development of 
porcine IPSCs (pIPSCs) can provide an alternative to porcine 
ESCs and can be used to further understand the biology of 
porcine ESCs. Such pIPSCs can also be used as a model to 
study various diseases. 
 
3.5.1 Factors used for reprogramming of porcine cells 
Several groups have attempted to reprogram porcine fibroblast 
cells into pIPSCs. Mouse transcription factors (Cheng, Li, Liu, 
Gao, & Wang, 2012), porcine factors(Liu et al., 2012) and 
human factors (West et al., 2010)have been used successfully 
to reprogram the porcine cells.  
 
3.5.2 Reprogramming techniques of porcine cells 




3.5.3 Retroviral and Lentiviral reprogramming 
Mainly, retroviral and lentiviral methods have been used to 
deliver the transcription factors into the cells. Ezashi et al 
(Ezashi et al., 2009) introduced four reprogramming genes into 
porcine fetal fibroblasts by means of a lentiviral vector. The four 
genes used were Oct4, SOX2, KLF4 and c-myc.  After twenty-
two days of culture, colonies were observed. Mouse 
transcription factors were also used to reprogram porcine 
fibroblast cells into IPSCs (Cheng, Guo, et al., 2012). Plasmids 
containing mouse transcription factors Oct4, SOX2, KLF4 and c-
myc were used in the packaging of retroviruses, and used to 
infect porcine fibroblast cells. IPS cell lines were derived and the 
morphology of the porcine IPS cells was similar to that of mouse 
embryonic stem cells.  
 
Lentiviral reprogramming was performed by Wu et al(Wu et al., 
2009). A doxycycline inducible lentiviral system was used. Oct4, 
SOX2, c-myc, KLF4, Lin28 and Nanog human cDNA was cloned 
individually into a lentiviral backbone. The rtTA gene was 
incorporated in a separate lentiviral vector. Lentiviruses from 
each of the vectors were mixed and porcine ear tip fibroblasts 
were incubated in the lentiviruses. After the viral infection, 
fibroblasts were seeded on MEFs and doxycycline was added to 
the culture media. Colonies were picked after 12 days of culture. 
 
3.5.4 Episomal reprogramming of Porcine IPS cells 
Telugu et al, have shown the generation of porcine IPSCs by the 
use of episomal plasmids.  Three episomal plasmids with a 
combination of several human pluripotent transcription factors 
were used, together with a mouse c-Myc vector. These plasmids 
were allowed to enter the cell through electroporation. The 
fibroblast cells were plated on to MEF feeders and they were 
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cultured in a media containing small molecules of PD0325901, 
an inhibitor of MAPK/ERK pathway and CHIR99021, a GSK3 
inhibitor, with the supplementation of Leukemia Inhibitory Factor 
(LIF). 1uM valporic acid was also added for 2 weeks. After 30 
days, the cell colonies were able to be picked and cultured 
(Telugu, Ezashi, & Roberts, 2010).  
 
3.5.5 Reprogramming with decreased number of 
transcription factors 
Other cell types such as porcine mesenchymal stem cells have 
also been successfully reprogrammed (Liu et al., 2012). 
Retroviruses were packaged using only 2 porcine factors Oct 4 
and KLF4 in combination with various small molecules.  
Although Oct4 has been found to be extremely crucial in the 
maintenance of pluripotency, porcine IPSCs have been 
generated without the exogenous expression of Oct4 
(Montserrat et al., 2012). Mouse cDNA of SOX2, KLF4 and c-
myc were cloned into a single plasmid with a retroviral backbone. 
Retroviruses were packed using this plasmid, and adult porcine 
fibroblasts were infected. The cells were then seeded on MEFs 
and compact colonies started appearing 8 days later. These cell 
colonies stained positive for alkaline phosphatase. This group 
then used SSEA4 as a pluripotent marker to identify cells that 
were fully reprogrammed. It was found that when Oct4 was 
included in the retroviral vector, there was a fewer percentage of 
colonies of cells that stained positive for SSEA4. Such SSEA4 
positive colonies also appeared later in culture. Hence, they 
postulated that cells that were less successfully reprogrammed 
when Oct4 was overexpressed. The group also went on to show 
that the reprogramming process did not need to be performed 
on MEFs. After viral transduction of the porcine fibroblasts, the 
infected cells were then seeded on gelatin coated plates. The 
cell colonies then appeared within the same time frame as those 
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reprogrammed on MEFs. Similarly, the cells that were 
reprogrammed with the inclusion of the Oct4 transcription factor 
had less SSEA4 positive colonies appearing, and such colonies 
appeared later. The advantage of not using MEFs is that it 
prevent the contamination of cells from other species. However, 
other groups have reported that the removal of Oct4 from the 
reprogramming process resulted in the decrease in the number 
of clones formed during the reprogramming process. They 
hence postulated that Oct4 was a critical factor in the 
reprogramming process and should not be withdrawn (Gao et al., 
2013). It was found that NANOG was more strongly expressed 
in the colonies reprogrammed with Oct4, compared to colonies 
that were not reprogramed with Oct4. This may also suggest the 
synergistic nature of NANOG and Oct4 in the transcription 
network which maintains the pluripotency of porcine IPS cells.  
 
3.6 Characterization and Definition of Porcine IPS cell 
lines 
Currently, there is no clear criterion on the definition of porcine 
IPSCs. Liu et al (Liu et al., 2012) found that the porcine IPSCs 
they generated did not express endogenous Oct4, Sox2, and 
Nanog when PCR was performed to determine gene expression. 
However, when using immunocytochemical staining, it was 
shown that the IPSCs express Oct4, Nanog and the specific 
mouse ESC-like pluripotent marker SSEA-1. Very few cells 
stained positive for typical human pluripotent markers SSEA4 
and Tra-1-81. Another group however (Yang, Mumaw, Liu, Stice, 
& West, 2013), was able to detect a different set of pluripotent 
markers that were positive. Oct4, Sox2, Nanog, SSEA4, Tra 1-
60 and Tra 1-81 were able to be detected by 
immunocytochemical staining. The expression of SSEA4, Tra 1-
60 and Tra 1-81 was endogenous as these transcription factors 
were not used during the reprogramming process. Another 
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group showed a different result on the pluripotency markers of 
porcine IPS cells (Ruan et al., 2011). It was found that the 
porcine IPS line had strong staining for Oct4, SOX2, SSEA-3, 
SSEA-4 and Tra-1-60. However, the staining for Nanog was 
weak. This was strongly correlated with the PCR performed by 
the group. The table 3.2 below shows the variation in the 
pluripotency characteristics that was obtained from various 
porcine IPSC lines generated by different groups (Ezashi, 
Telugu, & Roberts, 2012). 
 




Although there are differences between the various groups 
regarding the genes that code for the pluripotency of porcine 
IPSCs, there is no doubt about the 3 main transcription factors 
that take center stage in pluripotency. They are Oct4, Sox2 and 
Nanog. There is a difficulty of establishing porcine ESC lines 
due to the different developmental timeline compared to mice 
and humans; research has shown that the blastocysts do 
express pluripotent markers at various stages during its 
development in vivo. For example, at day 6 of development, the 
inner cell mass of the porcine blastocyst express Oct4. In fact, 
OCT4 is not only expressed by the inner cell mass, but also in 
the trophectoderm (Hall, Christensen, Gao, Schmidt, & Hyttel, 
2009). From day 9 of development, Nanog and SOX2 were able 
to be detected in the epiblast cells. At this developmental stage, 
OCT4 was found to be confined to the epiblast region as well. 
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Such co-expression of important transcription factors suggests a 
network that establishes pluripotency in the porcine embryo.  
 
3.7 Difference in culture methods of Porcine IPSCs 
Other inconsistencies in the culture of pIPSCs are in the various 
culture systems that have been used. Various groups have 
arrived at a cocktail that has been able to maintain the pIPSCs 
at a pluripotent state, based on the criteria that each group has 
set. Hence, with an undefined criterion for pluripotency, it is also 
unclear which culture method is useful for the long-term 
maintenance of pIPSCs. 
 
3.7.1 Culture media 
Thus far, groups are also unable to arrive at a consensus on the 
media components that are best suited for the growth of porcine 
IPSCs to maintain its growth and pluripotency. Yang et al (Yang 
et al., 2013) was able to derive and passage porcine IPSCs 
using regular human ESC media. Another group was able to 
maintain porcine IPSCs using Knockout DMEM supplemented 
with 20% FBS (Cheng, Guo, et al., 2012). A third group however, 
used a combination human ESC media and mouse ESC media. 
The components include the addition of KOSR and bFGF from 
the human ESC media, and FBS and LIF from mouse media 
(Cheng, Guo, et al., 2012).  
 
3.7.2 Culture on Matrigel 
With the use of Matrigel ™, some groups were also able to 
passage their porcine IPSCs up to 22 passages(Yang et al., 
2013). Karyotyping was performed after the 22 passages to 
determine the chromosomal stability, and the cells were found to 
have normal karyotypes. However, there were groups that were 
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not able to culture their porcine IPS cells on Matrigel™. The 
culture of the cells on Matrigel™ coated plates and on gelatin 
coated plates resulted in differentiation (Gao et al., 2013).  
 
3.8 Differentiation protocol that has been published for 
pigs 
The differentiation profile for porcine IPS cell lines has not been 
well studied, as there is no specific standard for pluripotency. 
Hence, many groups are still focused on the determination of 
the standard criteria for porcine IPS cell lines. However, some 
groups have attempted to differentiate their porcine IPS cell 
lines into various lineages. 
 
3.8.1 Neural 
To differentiate porcine IPSCs into neural lineages, porcine 
IPSCs were grown on Matrigel ™ coated dishes. When the cells 
became 80% confluent, the media was changed to neuron 
differentiation media for the next 10-20 days. To differentiate 
porcine IPS cells into motor neurons, neuron differentiation 
media was supplemented with retinoic acid and sonic hedgehog 
peptide for 7 days. After 7 days, various growth factors such as 
BDNF, GDNF and IGF1 were added into the media. The cells 
were then cultured as such for the next 14 days. It was shown 
that porcine IPSCs that were originally SSEA4 positive were 
able to form neurons and oligodendrocytes with the use of the 
above differentiation protocol (Yang et al., 2013). However, 





Hepatocytes are also important repair sources for the damaged 
liver. Hence, the option of using hepatocytes obtained from a 
porcine source is also being explored (Aravalli, Cressman, & 
Steer, 2012). Porcine IPS cells were cultured in embryoid bodies 
state, and they were plated on STo feeders. The growth media 
used was RPMI with the addition of B27 and Activin A. This 
media is able to direct the differentiation towards an endodermal 
lineage. After 5 days, several growth factors such as FGF-2, 
BMP-4 and HGF was added. After another 5 days, the media 
was replaced with RPMI/ B27 with Oncostatin M. With this 
differentiation protocol, hepatocyte like cells was able to be 
visualized in the plates.  
 
3.8.3 Cardiac differentiation protocol 
Thus far, there has been only one published protocol for the 
generation of porcine cardiomycytes from pIPSCs (Montserrat et 
al., 2011). In order to derive cardiomyocytes from pIPSCs, the 
pIPSCs were first scraped from the culture dish, and maintained 
in suspension for three days. The cells were then transferred 
onto gelatin coated dishes, and cultured in differentiation media 
that contains 20% FBS. Two days later, from day 5 up to day 
15-20, differentiation media was supplemented with 10mM 








4. Materials and Methods 
The materials and methods used in the experiments are described 
below. 
 
4.1 Culture of Mouse Embryonic Fibroblast (MEF) cells 
as feeder cells for hESCs. 
MEFs (PMEF-CFL, Millipore) were thawed and cultured in 
complete media.  
 
Table 4.1 Materials required for complete media 
Fetal Bovine Serum Hyclone SH30070.03 75ml 
Dulbecco’s Modified 
Eagle Medium 
Gibco, 11995-073 410ml 
MEM Non-essential 
Amino Acids 
Gibco, 11140-050 5ml 
Glutamax ™ Gibco, 35050-061 5ml 
Penicillin-Streptomycin Gibco,15140-122 5ml 
 
When the cells have reached confluency, the MEFs were 
treated with Mitomycin C (Kyowa Hakko Kirin) for 2.5hours. This 
is to arrest the growth cycle of the cells and to mitotically 
inactivate them. This prevents the cells from competing for 
nutrients with the hESCs. After the treatment, the cells were 
washed twice with PBS- (Gibco, 14200-075) to remove any 
remaining Mitomycin C. Trypsin (Gibco, 25200-072)  was then 
added to the cells and placed in the incubator for 5 minutes, 
37oC for the enzyme to take effect, and it was visibly observed 
that the cells have lifted off the surface of the culture flask. 
Complete media was then added to neutralize the trypsin. The 
 38 
cell suspension was then collected and centrifuged at 200g, 5 
minutes. The supernatant was removed and the cells were 
resuspended and frozen in 10% DMSO (Sigma Aldrich, D2650) 
until use. MEF was grown and treated in bulk for economies of 
scale as well as to save processing time. Cells would also be 
ready for use when required. However, the freezing down of 
MEF may decrease its viability when thawed for use.  
 
4.2 Culture of Human Embryonic Stem Cells (hESCs) 
There are generally 2 methods of culturing hESCs. The first 
method utilizes culture with feeders, while the second method 
involves the use of a substrate instead of cells as feeders. The 
culture methods are described below. 
 
4.2.1 Culture of Human Embryonic Stem Cells on MEF 
feeders 
0.1% gelatin (Sigma Aldrich, G1890) was prepared by dissolving 
gelatin in double-distilled water and autoclaved for sterility. 
Culture dishes were coated with 0.1% gelatin at least 2 hours 
before use. The gelatin was then removed and the plates left to 
dry. Mitomycin-C treated MEFs were then thawed and seeded at 
a density of 0.05 million cells/ cm2. The media was changed to 
hESC media supplemented with basic Fibroblast Growth Factor 
(bFGF). The materials required for hESC media is shown in 
table 4.2. The plates were left to equilibrate in the incubator at 







Table 4.2 Materials required for hESC media 
DMEM/ F12 Gibco, 10565-018 384ml 
Knockout Serum Replacement Gibco,10828-028 100ml 
MEM Non-essential Amino Acids Gibco, 11140-050 5ml 
Glutamax ™ Gibco, 35050-061 5ml 
Penicillin-Streptomycin Gibco,15140-122 5ml 
Beta-Mercaptoethanol, 55mM Gibco, 21985-023 1ml 
Basic Fibroblast Growth Factor   Gibco, 13256-029 10ng/ml 
 
After which, cells can be mechanically dissociated using a 30G 
needle. The fragments can be scrapped of the surface of the 
dish and transferred onto a plate of fresh feeders that was 
prepared earlier. Fresh media should be changed daily. 
 
4.2.2 Feeder- free Culture of Human Embryonic Stem 
Cells 
hESCs can also be cultured without a feeder layer. The 
advantage of not using a feeder layer is that it prevents cross-
contamination of the hESCs with feeder cells. 
Matrigel™basement membrane matrixis used to support the 
growth of the cells. mTesR1 is also used instead of the regular 
hESC media. As the cells are not grown on feeders, enzymes 
are required to detach the cells from the surface of the plate. For 
both feeder and non- feeder culture, 10uM ROCK Inhibitor 
(Sigma Aldrich, Y-27632) can be added to improve cell viability.  
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4.2.3 Coating of Matrigel ™ 
Matrigel™ (BD, 354277) is stored at-20oC, and is thawed 
overnight in 4oC before use. Pipette tips, tubes and media that 
will come in contact with Matrigel™ must be pre-cooled. 50µl of 
Matrigel™ is diluted in 1.45ml of DMEM/F12. Add 3ml of the 
diluted mixture into each 6cm dish. The dishes are then left 
overnight at 4oC. Before the dishes are used, they are first 
placed in the incubator for 20 minutes. After which, Matrigel™ is 
aspirated and fresh mTesR1 media is added. 
 
4.2.4 Enzymatic passaging of Human IPSCs 
The media is first aspirated, and washed with PBS to remove 
remaining media. Dispase (Invitrogen, 17105-041) is dissolved 
in DMEM to a concentration of 1mg/ml. Dispaseis then added to 
the dish, and incubated at 37oC for 4 minutes, or until the edges 
of the cell colony starts to curl of the surface of the dish. The 
dispase solution is then aspirated and fresh hESCmedia added. 
The cell colonies are then lifted of the surface of the culture dish 
using a cell scraper. The cell suspension is then centrifuged for 
3 minutes, 200g. The supernatant is then removed and fresh 
mTesR1 (Stemcell Technologies)media added. The cells are 
then seeded onto fresh culture dishes coated with Matrigel™. 
 
4.3 Differentiation of Human IPS cells into 
cardiomyocytes 
Two methods of deriving beating Embryoid bodies were used. 
The hESCs used in this experiment were grown on MEFs. 
 
i. hESCs were microdissected with a 30G needle into small 
clusters and they were lifted off the surface using a 
pipette tip. The cell clusters were then placed in ultra-low 
adhesion culture plates in hESC media. After an 
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overnight incubation, the media was then changed to 
Complete media with 20% FBS (thereafter known as 
EB20) supplemented with 5uM SB203580 (Sigma Aldrich, 
S8307) a p38 MAPK inhibitor. The media was changed 
every alternate day. After 8 days in suspension, the cells 
were then seeded on gelatin coated dishes.  
ii. The second method used a serum-free and insulin-free 
media for cardiomyocyte differentiation. Similar to the first 
method, the colonies were dissected and grown in 
suspension in ultra-low adhesion culture dishes. The 
media used for this experiment was a cardiomyogenic 
media (CARM). The materials required for CARM media 
is shown in Table 4.3. The clusters were then plated on 
0.1% gelatin coated plates from day 15. 
 
Table 4.3 Materials required for CARM media 
Dulbecco’s Modified 
Eagle Medium 
Gibco, 11995-073 480ml 
MEM Non-essential 
Amino Acids 
Gibco, 11140-050 5ml 
Glutamax ™ Gibco, 35050-061 5ml 
Penicillin-Streptomycin Gibco,15140-122 5ml 
Transferrin Sigma Aldrich, 
T8158 
0.0055 mg/ml 




Subsequently, EB aggregates were formed and contracting 
outgrowths emerged from Day 12 onwards. After Day 15, the 
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contracting EB aggregates were plated on 0.1% gelatin in 
DMEM containing 2% FBS.  
 
4.4 Patch clamp recordings of human IPS derived 
cardiomyocytes 
Whole cell patch-clamp recordings were performed using Axon 
200B patch clamp amplifier (Axon instrument, USA) and low-
pass filtered at 2-5 kHz. Data was recorded using the Digidata 
1440A. Borosilicate glass electrodes (1.5mm OD) were pulled by 
a horizontal puller (Model P-97, Sutter Instrument, USA) and 
fire-polished to a final resistance of 2-3 MΩ when filled with 
internal solution. Spontaneous APs were recorded from hiPSC-
CMs in normal Tyrode’s solution containing (in mM): NaCl 140, 
KCl 5.4, CaCl2 1.8, MgCl2 1, glucose 10, HEPES10, adjusted to 
pH 7.40 with NaOH. Pipettes solution was contained (in mM): 
KCl 130, NaCl 5, MgCl2 1, MgATP 3, EGTA 10, and HEPES 10, 
adjusted to pH 7.20 with KOH. Cells were maintained by a TC-
324B single channel heater controller (Warner Instruments) at 
35-37 °C during the recording. 
 
4.5 Culture of Porcine Fibroblast Cells 
Porcine dermal fibroblast cells were derived from a skin biopsy, 
taken from the groin region of a yorkshire pig. The skin biopsy 
was disinfected, and minced. The fragments were then placed in 
a culture dish and Complete media was added. Cells were 
allowed to grow out from the tissues. Upon confluency, the cells 
were passaged and frozen in 10% DMSO until use.  
 
4.6 Preparation of Plasmids for transfection 
A plasmid is a DNA molecule and replicates autonomously. The 
plasmids were obtained in the form of a bacterial pellet from Dr 
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Xiao Lei (Shanghai Institute of Biochemistry and Cell Biology). 
For our experiment, human cDNA sequences were cloned into a 
lentiviral plasmid. The backbone of the plasmid had a 
tetracycline operator to allow for doxycycline-inducible 
expression of the cDNA cloned into the plasmid.  The figure 
below shows the schematic of the plasmid sequence. The 
plasmids each carried either KLF4, c-myc, Oct4, Sox2, Lin28 or 
Nanog as a transgene. 
 
Figure 4.1 Schematic diagram of plasmid with human cDNA used for 
reprogramming 
  
Luria-Bertani Agar plates with Ampicillin were prepared by the 
following method. 800ml of double-distilled water was obtained. 
10g of bacto-tryptone, 5g yeast extract and 10g of NaCl was 
added to the water, and the pH value was adjusted to 7.5. 15g 
of agar was added, and the total volume was added to 1000ml. 
The solution was then autoclaved for sterility. After which, the 
solution was allowed to cool. Ampicillin (Sigma Aldrich, A9393) 
was added to a concentration of 50ul/ml. The solution was then 
poured into 10cm dishes, and the agar was allowed to solidify. 
The bacterial pellet was thawed and the sample was streaked 
on the Luria-Bertani Agar plate with ampicillin antibiotics. The 
agar plate was then incubated at 37oC, overnight.  
 
Luria-Bertani broth was also prepared with the same 
concentration of Ampicillin. Similarly, 10g of Bacto-tryptone, 5g 
of yeast, 10g of NaCl was added to double-distilled water. The 
pH was also adjusted to 7.5 and the volume of water was 
adjusted to 1000ml. LB broth was also sterilized by autoclaving.  
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Colonies on the agar plate was picked and culture overnight in 
5ml of LB broth. The cells were harvested the next day and a 
miniprep (Qiagen) was performed. After verification that the 
plasmids were of a correct size by restriction enzyme digestion, 
the bacterial stock was inoculated into a larger volume of LB 
broth for overnight culture. The bacterial cells were then 
harvested and a Maxiprep (Qiagen) was performed to purify the 
plasmids. The plasmids were then used for the packing of 
lentiviruses. 
 
4.7 Packaging of Lentiviruses for the induction of 
Pluripotent Stem Cells 
Virapower ™ Lentiviral Expression System (Life Technologies) 
was used in the packaging of the viral particles. 293T cells were 
seeded on 0.1% gelatin coated dishes at a density of 2 million/ 
6cm dish with Complete medium. Each dish was then 
transfected with 4 plasmids. They were:  
(1) Plasmid containing pluripotent transcription factor in a 
lentiviral backbone, 
(2) pLP1 vector,  
(3) pLP2 vector,  
(4) pLP/VSVG vector.  
 
The transfection was done as follows. 5µg of each plasmid was 
added into 300µl of Opti-MEM (Gibco, 3198070), and left to 
stand for 5 minutes. 12µl X-tremeGENE HP DNA transfection 
reagent (Roche, 06 366 546 001) was added to the mix and left 
at room temperature for 15 minutes for complexes to form. The 
mixture was then added to 293T cells in a dropwise manner. 
The cells were then incubated at 37oC with 5% CO2, overnight. 
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The media was changed the next day. 48 hours after the 
transfection was performed, the viral supernatant was collected. 
The viral supernatant was collected again at 36 hours post 
transfection.  
 
4.8 Infection of fibroblast cells to form Induced 
Pluripotent Stem Cells 
Fibroblast cells were seeded on 6 well plates at a density of 
100,000 cells/ well. The viral supernatant obtained was filtered 
through a 0.45nm syringe filter and polybrene (Millipore, TR-
1003-G) was added. The viral supernatant was then added to 
the fibroblast cells and incubated for 8 hours at 37oC with 5% 
CO2. Viruses were removed from the cells and complete media 
was added to allow the cells to recover overnight.  Another 
round of infection was performed on the fibroblast cells. Similarly, 
the viral supernatant was removed after 8 hours and complete 
media added to the cells. 
 
4.9 Culture of cells transitioning from fibroblasts to 
Induced Pluripotent Stem Cells 
After the infection process was completed, the fibroblasts were 
trypsinized and placed onto a 6cm plate with a fresh MEF feeder 
layer. The cells were seeded with complete media to allow them 
to attach to the culture dish. Media was changed to pIPSC 
culture media the next day.  
 
4.10 Culture of Porcine Induced Pluripotent Stem Cells. 
Porcine IPSC culture media was made by mixing mouse ESC 
media with human ESC media in a 1:1 ratio. The components of 
mouse ESC media are listed in table 4.4. 
 46 
 















Sigma Aldrich, D9891) was also added at a concentration of 
4ug/ml to ensure the expression of the exogenous pluripotent 
transcription factors. MEFs were seeded in culture dishes as 
feeder layers one day before the porcine IPSCs were to be 
passaged. Media was changed to porcine IPSCs and the 
feeders were allowed to equilibrate for 0.5 hours. Similarly to 
human ESCs, the colonies were disrupted mechanically into 
smaller pieces, and they were transferred onto fresh feeders 
that were prepared earlier.  
 
4.10 Characterization of Porcine Induced Pluripotent 
Stem Cells 
Several experiments were performed to determine the 
pluripotency of the porcine IPS cell lines. The methods and 
materials used are described below. 
Fetal Bovine Serum Hyclone SH30070.03 100ml 
Dulbecco’s Modified Eagle 
Medium 
Gibco, 11995-073 385ml 
MEM Non-essential Amino 
Acids 
Gibco, 11140-050 5ml 
Glutamax ™ Gibco, 35050-061 5ml 
Penicillin-Streptomycin Gibco,15140-122 5ml 
Beta-Mercaptoethanol, 55mM Gibco, 21985-023 1ml 
Recombinant Human Leukemia 
Inhibitory Factor 
Invitrogen,  PHC9483 1000U/ml 
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4.10.1 Immunocytochemical staining for Porcine IPSCs 
Immunocytochemical staining was performed on the cell 
colonies to determine the pluripotency status of the cells. 
Pluripotent genes include Oct4, SOX2, Nanog, Tra-1-60, Tra-1-
81, SSEA1 and SSEA4.  The primary antibodies used are 
shown in table 4.5 below. 
 
Table 4.5 Primary Antibodies used for immunocytochemical staining 
 
 
The cells were grown in a MEF layer on glass cover slips. The 
media was first aspirated from the cells, and the cells were 
washed with 1x PBS. The cells were then fixed in 4% PFA (EMS, 
15710) for 10 minutes. PFA was then aspirated and the cells 
were washed again with PBS to remove remaining traces of 
PFA. 0.01% Triton-X was then added to permeabilize the cells. 
After 10 minutes, Triton-X was removed and the cells were 
washed with PBS again. The cells were then blocked with 5% 
BSA/PBS to prevent non-specific binding of the antibodies, for 
30 minutes. The primary antibodies were then prepared. The 
Gene  Host Isotype 
Oct4 Millipore, Chemicon, MAB4401 Mouse  IgG1 
SOX2 Millipore, Chemicon, AB5603 Rabbit IgG 
Nanog R&D systems, AF1997 Goat IgG 
SSEA1 Millipore, Chemicon, MAB4301 Mouse  IgM 
SSEA4 Millipore, Chemicon, MAB4304 Mouse IgG3 
Tra-1-60 Millipore, Chemicon, MAB4360 Mouse IgM 
Tra-1-81 Millipore, Chemicon, MAB4381 Mouse IgM 
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antibodies were diluted in 1% BSA/PBS in a 1:200 dilution. The 
blocking solution was removed, and the cells were incubated in 
the primary antibodies for at least 2 hours, at room temperature. 
The cells were then washed with 0.05% PBST to remove 
unbound antibodies. The secondary antibody was then diluted in 
1% BSA/PBS in a 1:500 dilution and added to the cells.  The 
table 4.6 below shows the secondary antibodies that were used. 
 
Table 4.6 Secondary Antibodies used for Immunocytochemical 
Staining 
Gene Secondary Antibody 
Oct4 Alexafluor® A21425 
SOX2 Alexafluor® A21430 
Nanog Alexafluor® A21432 
SSEA1 Alexafluor® A21426 
SSEA4 Alexafluor® A21425 
Tra-1-60 Alexafluor® A21426 
Tra-1-81 Alexafluor® A21426 
 
The cells were then incubated in the secondary antibody for 1 
hour at room temperature.  The cells were then washed with 
0.05% PBST.  DAPI was then added for nuclear staining. The 








4.10.2 Polymerase Chain Reaction for Porcine IPSCs 
RNA was extracted from RNEasy Mini Kit (Qiagen) according to 
the manufacturer’s protocols. The RNA isolated was quantified 
and then stored at -80oC until use. The RNA was then converted 
into cDNA for PCR. Superscript® III First-Strand Synthesis Kit 
(Invitrogen 18080-051) was used to synthesize the first-strand 
cDNA, according to the manufacturer’s protocol. Primer design 
was performed using Primer-BLAST, available on the NCBI 
website.  
http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome 
Primers designed were then purchased from Sigma Aldrich. 
PCR was performed using the 2X PCR Master Mix w/ 1.5mM 
MgCl (Thermo Scientific). The cycling parameters are shown in 
the table below. The annealing temperature and the number of 
cycles vary across various genes, and will be recorded with 
each primer set.  
 
Table 4.7  Protocol for Polymerase Chain Reaction 
Stage 1 94oC 2 mins 
Stage 2 
94oC 20 secs 
xoC 30 secs 
72oC 1 min 
Stage 3 








After the PCR was performed, the samples were run on an 
electrophoresis gel to identify the bands that were amplified. 
Agarose powder (Bio-rad, 161-3102) was dissolved in 1x TAE 
(First Base, BUF-3000-10x1L) buffer. The stain used in the 
electrophoresis gel was Gelred™ Nuclei Acid Gel Stain (Biotium, 
41001). 
 
4.10.3 Teratoma formation 
The cell colonies from a 6cm dish were dissociated into small 
clumps via brief trypsinization. The trypsin was neutralized and 
the cells were centrifuged at 200g, 5 minutes. The supernatant 
was removed, and the cells were resuspended in 100ul of 
complete media. The cell suspension was then injected into 2 
sites in a SCID mouse, both subcutaneously, as well as into the 
renal capsule, according to approved IACUC procedures.  The 
animal was monitored for the formation of tumors.  
 
4.10.4 Karyotyping 
Porcine IPSCs cultured in a T-25 flask, and freshly prepared 
feeders. After 3 days of culture, the cells were then sent for 
karyotyping at Cell Line Genetics. 
 
4.10.5 Alkaline Phosphatase Staining 
Alkaline Phosphatase staining was performed on the cell 
colonies grown on MEF feeders.  Alkaline Phosphatase Staining 
Kit II (Stemgent, 00-0055) was used. The staining was done 







4.11.1 In vitro teratoma  
The porcine IPS cells were differentiated in vitro to determine if 
they had differentiation potential. The cells were scraped from 
the culture surface and allowed to form embryoid bodies 
overnight. The media used was EB20, without the addition of 
any small molecules to allow the cells to differentiate 
spontaneously. After 7 days in culture, the RNA of the cells were 
extracted. The RNA was then converted to cDNA and PCR was 
performed to determine if markers from 3 germ layers were 
present. To determine the presence of the endoderm layer, 
primers for Alpha -fetoprotein were used. For mesoderm, 
primers for brachyury were used. Also, for ectoderm, PCR was 
performed for the gene fgf5. 
 
4.11.2 Differentiation into fat and cardiomyocytes 
Differentiation of Porcine Induced Pluripotent Stem Cells was 
performed using 2 different types of media. The first protocol 
used complete media with 20% FBS.  The second protocol 
replaced the FBS component with 20% porcine serum (Sigma 
Aldrich, 9783). After 4 days from the previous passaging, the cell 
colonies had grown to a size that was suitable for passaging and 
differentiation. The cells were scraped from the culture surface 
and placed into ultra-low adhesion plates in hESC media, similar 
to the differentiation protocol for human IPS cells.  EBs were 
then allowed to form. The next day, media was then changed to 
differentiation media containing either FBS or porcine serum, 
supplemented with 50uM Ascorbic Acid. After 8 days in 
suspension, the cells were seeded on gelatin coated dishes, and 
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the EBs were allowed to attach. The gene expression and 
morphology of the cells were analyzed at day 21 of differentiation. 
 
4.11.3 Staining of fat globules 
Oil red O (Sigma Aldrich, O9755) was used for the staining of fat 
cells. Oil red O crystals were weighed, and 300mg of the 
crystals were added to 100ml of 99% isopropanol to form the 
stock solution. 3 parts of the stock solution was then added to 2 
parts of deionized water and left at room temperature for 10 
minutes. The solution was then filtered. The media was 
aspirated from the culture vessel and 10% PFA was added. The 
cells were fixed for 30 minutes at room temperature. PFA was 
aspirated and the cells were washed with water. 60% 
isopropanol was then added for 2 minutes. The isopropanol was 
removed and the oil red O solution was added to the culture dish 
for 5 minutes. The oil red O solution was then removed and the 
dish was rinsed with water. The staining was then visualized 















5.1 Morphology of hESC 
The morphology of the hESCs that were grown on MEFs and on 
Matrigel™ were similar to that of published literature. The cell 
colonies have clearly defined borders and the individual cells 
had large nuclear-to-cytoplasm ratio. The cells were passaged 
every 7 days, and the cells were able to be maintained in an 
undifferentiated state after several passages. 
 
 
Figure 5.1 Brightfield image of hES cell colony grown on Matrigel™ 
with 4x zoom. The colony has clearly defined borders. The passaging 
cycle was in accordance with literature and the colony was passage 





Figure 5.2 Brightfield image of hESCs with 20x zoom. Distinct nuclei 
was present within the cells. Multiple nuclei was also observed inside 
each cell, which is characteristic of hES cell lines. There is also a large 
nuclei to cytoplasm ratio being observed. 
 
5.2 Morphology of iPSCs 
The morphology of the iPSCs obtained was similar to that of 
hESCs. The iPSC colonies have a similar passaging cycle to 
that of the hESCs. The cells within the cluster were also small 
and compact, and similarly, had a large nuclear-to-cytoplasm 
ratio. The cells were also able to remain in an undifferentiated 





5.3 Differentiation of hESCs / hIPSCs into 
cardiomyocytes 
Regardless of which differentiation technique was used, beating 
clusters were observed from 15 days post embryoid body 
formation.  
 
Figure 5.3 Brightfield image of Embyoid Bodies attached to a gelatin 
coated culture surface. Cells were observed to start beating from day 











5.4 Action potential recording of IPS derived 
cardiomyocytes 
 
The main function of cardiomyocytes generated is the ability to 
contract. Such contractions are a result of electrical signals 
known as the action potential. I have dissociated human 
cardiomyocytes from the beating embryoid bodies. Such isolated 
cells are subjected to patch clamp recordings with guidance. 
Figure 5.4 shows the spontaneous ventricular like action 




Figure 5.4 Action potential recording from a ventricular cardiomyocyte 
derived from human IPS cells derived from my culture. 
 
There are several phases in the action potential of a 
cardiomyocytes. Phase 0 is a depolarization phase where the 
voltage increases past the 0mV level. This is due to an increase 
in the sodium ions entering the cells. In phase 1, the 
permeability of the sodium ions to the cell decreases, and hence 
this leads to a repolarization of the voltage across the cell 
membrane, and this result in a decrease of the potential. In 
phase 2, which is commonly known as the plateau stage, the 
calcium ions moving into the cell is the same as the potassium 
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ions flowing out of the cell. As the permeability of the cell to 
potassium increases, the potassium ions continue to flow out of 
the cell, resulting in a drop in the potential across the membrane 
in phase 3. The voltage then drops to the original value in phase 
4, until the next action potential is triggered.  
 
5.5 Culture of porcine fibroblast cells 
Outgrowths of cells were observed from the skin biopsy about 5 
days in culture. The outgrowths of cells had regular fibroblastic 
morphology, and were spindle like. The cells could be passaged 
in culture media supplemented with fetal bovine serum, and did 
not require media supplemented with porcine serum. The cells 




Figure 5.5 Outgrowth of porcine fibroblast cells from a skin biopsy 
taken from the groin region of a Yorkshire pig. The cells had regular 




5.6 Reprogramming process of porcine fibroblast cells 
After the transfection of the 293T cells, the cells were observed 
to express GFP. This signifies that the plasmid carrying the 
cDNA of the pluripotent factors has successfully been 
transfected. The brightness of the GFP is stronger in the cells 
transfected with the various pluripotent genes compared to that 
transfected with the plasmid containing the rtTA gene.  
 
 
Figure 5.6 Representative image of GFP expression in transfected 
293T cells. The expression of GFP signals a successful transfection, 
and shows that the plasmid containing the cDNA of pluripotent factors 
have entered the cell. However, this does not mean that the 
production of viruses is successful. 
 
After the viral supernatant was harvested, porcine fibroblast 
cells were infected. Similarly, the GFP being expressed in the 
fibroblasts is an indication of the successful infection. This also 
signifies that the viral packaging procedure is successful. After 
the infection process, the cells were seeded onto MEFs. The 
porcine fibroblast cells were able to attach, and spindle-like 
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shaped cells were able to be observed on the surface of the 
feeder cells. Figure 5.7 shows the GFP positive porcine 
fibroblast cells that have been successfully transfected by 
lentiviruses. The transfected cells were able to show GFP 
expression by day 4 after lentiviral transfection. 
 
 
Figure 5.7 Representative image of GFP expression in porcine 
fibroblast cells that have been successfully infected with lentiviruses. 
The infected cells were able to attach onto a feeder layer and they 










5.6  Formation of Porcine IPS colonies and the 
continuous culture of the colonies 
After approximately 5 days in culture, small clusters of cells 
became visible. The original fibroblast cells that were originally 
spindle shaped had begun to round up and appeared packed. 
The cells continued to express GFP in the presence of 
doxycycline. Doxycycline allows for transcription of the GFP 
gene as well as the pluripotent transgene. The exogenous 
expression of the pluripotent factors allows the change in 




Figure 5.8 Brightfield image of colony that had just formed, 5 days 
after infection. Some cells have begun to show dense nuclei within the 
cell. The cells have also changed in morphology, where the original 
spindle shaped fibroblasts have rounded up and are closely packed. 






Figure 5.9 GFP expression of a new porcine IPS colony. In the 
presence of doxycycline, which allows the forced expression of the 
GFP gene and the pluripotent transgene. 
 
The clusters were allowed to increase in size, and they were 
excised with a 30G needle onto fresh feeder layers. Clusters 
were chosen based on their morphology with high nuclear to 
cytoplasmic ratio. The cells within the clusters also has to be 
closely packed. The small clusters were observed to have 
attached the next day. Approximately 20 clusters were excised 
and transferred to fresh feeder layers. The media was changed 
daily to ensure a fresh supply of nutrients for the newly formed 
porcine IPSC. The passage cycles were 7 days during the early 
passages. After the cells were stabilized in their epigenetic 
status, the doubling time of the cells was shortened, and the 
passaging cycle reduced to a 4 day cycle. There were 3 distinct 
colonies that were isolated, and they were given names C1, C5 
and C7. Figure 5.9 shows a porcine cell colony at 4x 





Figure 5.10 Colony of Porcine Induced Pluripotent Stem Cells. The 
brightfield image is taken at 4x zoom. The IPS colony also has distinct 




Figure 5.11 Colony of Porcine Induced Pluripotent Stem Cells. The 
brightfield image is taken at 10x zoom. Distinct nucleus can be 
observed, and the morphology is similar to human IPSCs. 
 
The morphology of the porcine IPSCs is rather similar to hESCS 
and human IPSCs. The colonies have a defined border, and the 
cells have a distinct nucleus with a large nuclear-to-cytoplasm 
ratio. However, it was noticed that at the end of the passaging 
cycle, the cell colonies grew thicker in the middle of the colony, 
and the cells were no longer homogenous. Hence, when the 
cells were microdissected, the centre of the parent colony was 
not used for subsequent cultures.  
 
The concentration of doxycycline was also reduced by half, to 
ensure that the pluripotency of the cells are not reliant on the 
expression of exogenous factors, and that there will be an 
activation of the endogenous pluripotent factors. With the 
decrease in the concentration of doxycycline, the cells were still 
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able to retain a morphology that is characteristic of pluripotent 
cells. 
The porcine IPSCs were also grown using a feeder free system.  
The culture system was similar to those of human cells, with the 
exception of the addition of doxycycline and LIF to the media. 
Similarly to colonies grown on MEFs, the cells in the cluster 
show a distinct nucleus. However, the reprogrammed cells were 
not able to survive well under feeder free conditions and they 
were only able to be passaged up to 3 consecutive passages 
before massive differentiation as observed. The addition of 
doxycycline and LIF was not able to maintain the pluripotency of 
the cells.  
 
 
Figure 5.12 Porcine IPS cell colony grown on Matrigel™. These cells 
also show obvious nuclei and the cells were closely packed within the 
colony. However, they were not able to be passaged beyond 3 
passages on Matrigel™, even though there was the addition of 




5.7 Characterization of Porcine IPS cells 
Several experiments were performed to characterize the IPS 
cells that were obtained.  
 
5.7.1 Immunocytochemical Staining of Porcine IPS 
colonies 
In order to evaluate the pluripotency of the IPS cells generated, 
immunocytochemical staining was performed on the cell 
colonies. Several pluripotent markers were used. They were 
Oct4, SOX2, Nanog, SSEA1, SSEA3, Tra-1-60 and Tra-1-81. 
These markers have been shown to positively stain cell colonies 
in several, but not all research groups. From the staining, it is 
observed that our cell colonies that were generated stained 
positive for Oct4, SOX2 and Nanog, which is shown in red. The 
positive GFP expression due to the expression of the 
exogenous transgene is shown in green. DAPI was also used to 
stain the nucleus of the cells. A composite of the various 
fluorescent images is also shown. The positive 
immunocytochemical staining results are shown below in 
Figures 5.13 to 5.15.  The other pluripotent markers did not have 
positive staining. The negative results are also shown in Figures 
5.16 to 5.19. One observation made was the lack of 
homogenous staining in all the cells of the colony. Not all the 
cells in the entire colony were stained positive for the pluripotent 
markers. In addition, immunochemical staining of the pluripotent 
genes did not completely overlap with the GFP positive cells. 
This could be due to the thickness of the IPS cell colony. The 
cells within the colony could be expressing GFP while the cells 
that are stained positive in red are on the surface. Hence, it can 
be observed that there are more cells being labelled in green 













Figure 5.13 Immunocytochemical staining of Oct4. The green 
fluorescence shows the GFP expression in A.  The positive staining of 
Oct4 is shown in red fluorescence in B. DAPI was also used to stain 




















Figure 5.14 Immunocytochemical staining of Sox2. The green 
fluorescence shows the GFP expression in A.  The positive staining of 
Sox2 is shown in red fluorescence in B. DAPI was also used to stain 








Figure 5.15 Immunocytochemical staining of NANOG. The green 
fluorescence shows the GFP expression in A.  The positive staining of 
NANOG is shown in red fluorescence in B. DAPI was also used to 










Figure 5.16 Immunocytochemical staining of SSEA3. The green 
fluorescence shows the GFP expression in A. There was no positive 
staining of SSEA3 that was detected in the red channel as shown in B. 
DAPI was also used to stain the cell nucleus in C. The overlaid images 







Figure 5.17 Immunocytochemical staining of SSEA1. The green 
fluorescence shows the GFP expression in A. There was no positive 
staining of SSEA1 that was detected in the red channel as shown in B. 
DAPI was also used to stain the cell nucleus in C. The overlaid images 







Figure 5.18 Immunocytochemical staining of Tra-1-60. The green 
fluorescence shows the GFP expression in A. There was very slight 
positive staining of Tra-1-60 that was detected in the red channel as 
shown in B. DAPI was also used to stain the cell nucleus in C. The 



















Figure 5.19 Immunocytochemical staining of Tra-1-81. The green 
fluorescence shows the GFP expression in A. There was positive 
staining of Tra-1-81 that was detected in the red channel as shown in 
B. DAPI was also used to stain the cell nucleus in C. The overlaid 
images are shown in D. 
 
5.7.2 PCR for exogenous genes in Porcine IPS 
As seen in the structure of the plasmids that have been used to 
reprogram the porcine fibroblasts, each transcription factor was 
cloned into individual plasmids. Reprogramming has also been 
performed by varying number of plasmids that have been used 
in the transfection. Hence, PCR is performed to determine the 
presence of exogenous factors. PCR primers were designed to 
detect human cDNA for Oct4, SOX2, c-myc and KLF4, which 
are traditional Yamanaka factors. Using the BLAST software 
from NCBI, primers have been designed, and they are shown in 
Table 5.1. The number of cycles and the annealing 
temperatures that have been used to perform the PCR are also 






Table 5.1 PCR primers for exogenous transcription factors 
Gene  Sequence Annealing 
Temperature 
Cycles 
Nanog F 5’-TAGTGAACCGTCAGATCGCC-3’ 59.6 30 
R 5’-TTCAGGCCCACAAATCACAGG-3’ 
Oct4 F 5’-TAGTGAACCGTCAGATCGCC-3’ 60.3 30 
R 5’-GAAGCTTAGCCAGGTCCGAG-3’ 
Sox2 F 5’-TAGTGAACCGTCAGATCGCC-3’ 60.1 30 
R 5’-CCGAGTTTGCATCTTGGGGT-3’ 
KLF4 F 5’-TAGTGAACCGTCAGATCGCC-3’ 59.6 30 
R 5’-AGAGCGAACGTGGAGAAGATG-3’ 
b-actin F 5’-TGCGGCATCCACGAAACTAC-3’ 60 30 
R 5’-TTCTGCATCCTGTCGGCGAT-3’ 
 
RNA from the porcine IPS cell colonies were extracted and 
converted to cDNA. PCR was performed on the cDNA and the 
PCR products were ran on an electrophoresis gel. The bands 




Figure 5.20 PCR bands for exogenous transcription factors. 
 
As seen from Figure 5.20, C1 and C5 carried all 4 exogenous 
genes that PCR was performed for. However, the exogenous 
SOX2 was not present in C7. This shows that not all factors are 
necessary for the fibroblast cells to be transformed into 
pluripotent cells. We have noted that the loading for each of the 
individual samples were not consistent, and hence, we have not 
drawn any conclusion about the levels of each gene present in 
each of the cell lines. Through this experiment, we have 
ascertained the presence of the various pluripotent genes in the 







5.7.3 PCR for endogenous genes in porcine IPS 
Next, PCR was performed to determine if the endogenous 
genes in the porcine IPS cells are being expressed. PCR 
primers for NANOG were designed according to the sequence 
of porcine mRNA of the for various pluripotent transcription 
factors.  The other primers used were obtained from literature 
(Fujishiro et al., 2013). The details of the primers used, including 
the sequence, annealing temperature and the number of cycles 
are shown in Table 5.2.  
 
Table 5.2 PCR primers for endogenous transcription factors 
Gene  Sequence Annealing 
Temperature 
Cycles 
Nanog F 5’-AGGGCTCAGCCAGTACAGAA-3’ 56 30 
R 5’-CAACATAGTTGTTGAGCTGG-3’ 
Oct4 F 5’-GCTGACAACAACGAGAATCTGC-3’ 59 30 
R 5’-ACGCGGACCACATCCTTCTCTAG-3’ 
Sox2 F 5’-AATGCGCACAGCGCGGCT-3’ 59 30 
R 5’-GCCCATGGA ACCGAGCGT-3’ 
KLF4 F 5’-CCATGGGCCAAACTACCCAC-3’ 58 32 
R 5’-TGGGGTCAACACCATTCCGT-3’ 
 
The expression of endogenous genes shows that the IPS cells 
have kick-started their own machinery and they are actively 




Figure 5.21 PCR bands for endogenous transcription factors 
 
As seen in Figure 5.21, endogenous Oct4 is present inC1 and 
C5. However it is not present in C7. Endogenous SOX2 is not 
present in all our porcine IPS cells. NANOG appears to be 
expressed in all the various clones, however, to varying extents. 
It is expressed much stronger in C1 and C5 compared to C7. As 
a control, RNA was extracted from fibroblasts cells as well to 
determine the expression of pluripotent factors in the parental 
fibroblasts. It is observed that the fibroblasts do not express 
Oct4, SOX2 and NANOG, however, there is the expression of 
KLF4 in the parental fibroblast cells. It is also observed that 
KLF4 is expressed endogenously in all 3 clones. 
 
5.7.4 Teratoma formation 
Teratoma formation was performed to ascertain if the cells were 
able to form 3 germ layers in vivo. However, our cells were not 
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able to form teratoma in vivo. There were no tumors formed in 
the renal capsule nor in the subcutaneous region of the mouse. 
 
5.7.5 Karyotyping of IPS clones 
C1 and C5 were sent for karyotyping. The figure 5.22 and 5.23 








Figure 5.23 Karyotyping results for Porcine IPS cell line C5 
 
From the karyotyping results, it was confirmed that there were 
no chromosomal aberrations in the porcine IPS cell lines that 
were generated. There was a normal chromosomal count in both 
clones even though there were epigenetic changes when the 
parental fibroblasts were converted to IPS cells.  
 
5.7.6 Alkaline Phosphatase Staining of Porcine IPS colonies 





Figure 5.24 Alkaline phosphatase staining of porcine IPS cell colonies 
 
As seen in figure 5.24, the porcine IPS cell colony was stained 
positive for alkaline phosphatase. The positive staining shows a 
purplish-pink colouration on the colony.  
 
5.8 Withdrawal of bFGF from the culture media 
Literature has shown that the addition of leukemia inhibitory 
factor (LIF) into the culture media is crucial for the maintenance 
of the porcine IPS in the pluripotent state. However, there have 
been reports that the colonies will maintain their pluripotency 
even with the withdrawal of bFGF. Hence, bFGF was removed 
from the culture media, and immunocytochemical staining was 








Figure 5.25 Immunocytochemical staining for expression of Oct4, for 
porcine IPS cell colonies cultured in the absence of bFGF. The green 
fluorescence shows the GFP expression of the transgene OCT4 in A, 
and the positive staining of OCT4 is shown in red fluorescence in B. C 






Figure 5.26 Immunocytochemical staining for expression of Sox2, for 
porcine IPS cell colonies cultured in the absence of bFGF. The green 
fluorescence shows the GFP expression of the transgene Sox2 in A, 
and the positive staining of Sox2 is shown in red fluorescence in B. C 






Figure 5.27 Immunocytochemical staining for expression of Nanog, 
for porcine IPS cell colonies cultured in the absence of bFGF. The 
green fluorescence shows the GFP expression of the transgene 
Nanog in A, and the positive staining of Nanog is shown in red 
fluorescence in B. C shows the DAPI stain, while D is an overlay of all 
3 channels. 
 
With the removal of bFGF from the culture, it was observed that 
the cells continued to express the pluripotent factors of Oct4, 
SOX2 and NANOG. The morphology of the cells also remained 
similar to that of that of the pluripotent cells, where the cells were 
packed closely in the colony, and the cells has a large nucleus to 
cytoplasm ratio. 
 
5.9 In vitro teratoma formation 
In order to determine if the porcine IPS cells are able to 
differentiate into 3 germ layers, the cells were differentiated in 
vitro, to form 3 germ layers. PCR was performed to determine if 





spontaneous differentiation. The table below shows the primer 
sets used to detect the expression of such genes. The primers 
were taken from literature (Chen, Lu, Cheng, Peng, & Wang, 
2011). 
 
Table 5.3 Primers used for determination of the presence of 3 germ 
layers 
Gene  Sequence Annealing 
Temperature 
Cycles 
Brachury F AAGAAACGGCAGGAGGATGG 58 38 
R CTCTGGGAAGCACTGGC 
FGF5 F TCACGGGGAGAAGCGTCT 51 38 
R ACTTGGCACTTGCATGGA 




Figure 5.28 PCR bands observed from the three germ layers. The 
presence of the bands shows the ability of the cells to differentiate into 
3 germ layers spontaneously. 
  
As seen from the figure 5.28, the cells were able to express 
markers from 3 different germ layers, namely mesoderm 
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(Brachyury), ectoderm (FGF5), and endoderm (alpha-
fetoprotein). A no template control was used to ensure that 
bands were not from contaminants.  
 
5.10 Differentiation of porcine IPS cells into fat and 
cardiomyocytes 
 
In order to differentiate the cells to cardiomyocytes, the cells were 
allows to form embryoid bodies in suspension. The embryoid 
bodies formed were darker than that of embryoid bodies formed 
by human IPS cells. Also, the embryoid bodies had edges that are 
fuzzier than human IPS embryoid bodies. Figure 5.29 shows the 
brightfield image of the embryoid bodies that were formed.  
 
 
Figure 5.29 Brightfield image of embryoid bodies formed by porcine IPS 
cells 
  
After 8 days in suspension culture with media containing FBS and 
vitamin C for directed differentiation, the cells were plated down 
on a gelatin coated culture surface. After 21 days, the formation of 
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fat globules was observed in the outgrowths of the embryoid 
bodies. The cells were then stained to confirm the presence of fat. 
Figure 5.30 and Figure 5.31 show the staining of the fat globules 
with oil red O.    
 
 




Figure 5.31 Oil Red O staining to identify fat cells. Image was taken at 
20x magnification 
 
Although we were not able to observed beating cells, we were 
able to show differentiation towards to mesodermal lineage. In 
order to further investigate the differentiation towards 
cardiomyocytes, the differentiation media was modified. Instead 
of the traditional use of FBS in the differentiation media, the FBS 
component was replaced with porcine serum. Similar 
differentiation methods were used and vitamin C was also used 
to direct the differentiation towards the mesodermal lineage. 
Similarly, after the embryoid bodies were plated on a gelatin 
coated surface, there were outgrowths of cells. The brightfield 





Figure 5.32 Image of embryoid body with cellular outgrowths 
 
After the change in culture media, the outgrowth of cell 
continued to show fat globules. In order to determine if there 
were any cardiomyocytes among the differentiated cells, the 
RNA of these cells was extracted, and RT-PCR was performed. 
Table 5.4 shows the primers used to detect the cardiac markers.  
 
Table 5.4 PCR primers to determine the presence of cardiomyocytes 


















Figure 5.33 PCR image of cardiac markers. Presence of bands show 
the expression of the cardiac markers. 
 
As seen in figure 5.33, RT-PCR bands can be observed for 
cardiac markers such as ACTN2, MLC2v, and cTNT. Hence, 
there may be the possibility of differentiation into cardiac cells. A 














6.1. Morphology of porcine IPS cells 
The morphology of porcine IPS cells have been shown in 
literature to be similar to that of human ESCs. The population 
doubling time was short, and the colonies had clear boundaries. 
The cells also have a high nucleus to cytoplasm ratio (Ruan et 
al., 2011). Our cells also have a morphology that is comparable 
to human ESCs.  
 
6.2 Expression of pluripotent genes in porcine IPS cells 
There have been studies on the expression of pluripotent 
markers in porcine IPS cells. However, it has been shown in 
literature that various groups have varying definitions of the 
factors that regulate the pluripotency of the cells. Some groups 
have determined that porcine IPS cells are regulated by the 
same genes as human pluripotent cells, and such porcine cells 
express such genes, shown by immunocytochemical staining or 
RT-PCR (Yang et al., 2013). Comparing the porcine IPS cells 
that we have generated, we have been able to show that our 
cells express the main pluripotent factors such as Oct4, SOX2 
and NANOG through immunocytochemistry. Through RT-PCR, 
we have also shown that our porcine IPS cells are able to 
express exogenous Oct4, SOX2, KLF4 and NANOG. The cells 
are also able to express endogenous Oct4, KLF4 and NANOG. 
However, the porcine cells are not positive for other factors such 
as Tra-1-81 and SSEA4. There have also been other porcine 
IPS lines generated that did not express the whole panel of 
pluripotent factors (Ezashi et al., 2009). 
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It is also postulated that there may be differences in the 
pluripotent genes that regulate the epigenetic status of porcine 
IPS cells. The porcine epiblast(Gao, Hyttel, & Hall, 2011) has 
been shown to weakly express NANOG and c-myc, which have 
led some to believe that such factors are not crucial in the 
regulation of pluripotency in porcine cells. Hence, it is important 
to determine the significant genes that play crucial roles in the 
signaling processes in porcine IPS cells. This may potentially 
increase the success of reprogramming for porcine IPS cells, as 
well as the downstream differentiation processes.   
 
6.3 Function of LIF in the culture of porcine IPS cells 
It has been shown that LIF is necessary in the culture of porcine 
IPS cells. Typically, human IPS cells have been cultured in 
KOSR and bFGF. However, it was shown that the addition of 
FBS and LIF during the reprogramming process was able to 
increase the number of colonies formed. It was observed that 
porcine IPS has LIF receptors and the removal of LIF from the 
culture media of porcine IPS cells can cause the cell to 
differentiate. In order to investigate the effect of LIF, RT-PCR 
was performed on LIF receptors. It was found that there was an 
increase in the expression level of LIF receptors compared to 
that of the porcine fibroblast cells. LIF is also an important 
activator of several signalling pathways, including JAK-STAT 
pathway. The activation of the JAK-STAT pathway is important 
to ensure that the IPS cells remain in a pluripotent state. In order 
to determine the role of LIF in the JAK-STAT pathway, JAK1 
inhibitor was added to block the JAK signalling, and it was found 
that the porcine IPS cells had lost their pluripotency(Cheng, 
Guo, et al., 2012). It was found that the cells no longer 
expressed alkaline phosphatase.  
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However, in the same series of experiments, bFGF was 
withdrawn from the media, and it was found that the cells were 
able to remain in the pluripotent stage. Similar results were 
obtained in our experiments. bFGF was able to be removed and 
the porcine IPS were still able to be stained positive for several 
pluripotent markers, including Oct4, SOX2 and NANOG. 
However, with the removal of LIF, our cells lost the typical ESC 
morphology, and we were no longer able to observe cells with a 
high nuclear to cytoplasm ratio. However, there is literature that 
suggests pig embryonic cells lack the components of the LIF 
pathway. Hence, their porcine IPS cells generated did not 
require the addition of LIF to maintain the pluripotency. Instead, 
it was believed that the feeder cells function as a source of LIF.  
 
6.4 Importance of doxycycline in the culture media 
The use of doxycycline inducible systems for the generation of 
IPS cells were effective in silencing the exogenous genes used 
in the reprogramming process (Wu et al., 2009). However, with 
the total removal of doxycycline, our IPS lines differentiated 
rapidly, and the cells no longer had the typical morphology of 
IPS cells. It was also shown in reports that doxycycline could not 
be withdrawn from the culture media of porcine IPS cells which 
were generated using a similar system. It was postulated that 
the culture conditions may not be sufficient or optimal for the 
cells to remain in the pluripotent state (Hall et al., 2012). The 
lack of factors in the culture media may not allow for the 
expression of endogenous genes and hence the pluripotency of 
the cells may be reliant on the expression of various exogenous 
pluripotent genes. The amount of doxycycline added to the 
culture media would be proportional to the amount of exogenous 
transgene expressed (Blau & Rossi, 1999). During the course of 
the experiments, the amount of doxycycline was reduced by half, 
and the porcine cells were able to still maintain the morphology 
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of pluripotent cells. The activation of endogenous genes were 
also observed through the use of RT-PCR. Although the 
continuous expression of exogenous genes was necessary for 
the pluripotency of the porcine IPS cells, there was also the 
activation of endogenous genes. However, we postulate that the 
expression of the selected endogenous genes may not be 
sufficient to sustain the cells for prolonged culture. This may be 
due to the lack of other critical growth factors in the culture 
media. Further work may be necessary to define the culture 
conditions best suited to porcine IPS cells.  
 
6.5 Differentiation of porcine IPS cells into cardiomyocytes 
Thus far, we were not able to differentiate the porcine IPSC to 
beating cardiomyocytes in our culture. However, we were able to 
detect cardiac markers that were present in the culture. The 
expression of these cardiac markers could come from 
precursors of cardiomyocytes and hence are cells that may not 
beat. This may explain why no beating cells were observed. 
Also, there may be the possibility of the presence of beating 
cardiomyocytes, but the efficiency of the production of 
cardiomyocytes was extremely low, and the beating cells were 
too few to be observed visually. Though their observed 
differentiation towards fat cells suggested that mesodermal 
differentiation was initiated, but directing the lineage towards 
cardio-mesoderm and subsequent cardiomyocytes remains to 
be elucidated.  
 
6.6 Use of porcine cells for other downstream work 
Although the porcine IPS cells were not able to differentiate into 
cardiomyocytes, it is possible to consider the use of the porcine 
IPS cells for other downstream experiments, such as the 
differentiation of the cells into mesenchymal stem cells. Studies 
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have shown that through the differentiation of IPS cells, MSCs 
can also be obtained alongside the IPS cells (Wei et al., 2012). 
Differentiated cells which do not exhibit cardiomyocte behavior 


























7.  Future work 
The understanding of the developmental biology of porcine 
embryonic stem cells will enable us to understand the signaling 
pathway of such cells and the culture conditions to maintain the 
pluripotency of porcine pluripotent stem cells. There have been 
several groups that each have their own definition of porcine 
pluripotent cells, and it is important to standardize such 
standards to ensure that the porcine IPS cell lines generated are 
of good quality and of good differentiation potential. 
The differentiation of porcine IPS cells into cardiomyocytes has 
only been shown by one group. The results have not been 
reproduced by other laboratories and we similarly failed to 
differentiate the porcine IPSC following that published protocol. 
Further investigations will need to be done to improve the 
cardiac differentiation protocol. The potential divergent of 
signaling pathways for cardiomyocytes differentiation in pig and 
human should be investigated in detail as cardiac differentiation 
protocols that worked in human IPSC failed to elicit similar 











8.        Conclusion 
We have successfully generated multiple lines of porcine IPS 
cells with pluripotent differentiation potential. These cell lines 
serve to provide valuable bench-top model for studying 
mesoderm differentiation and cardiomesoderm commitment for 
better understanding of the divergent differentiation cascade 
























Ameen, C., Strehl, R., Bjorquist, P., Lindahl, A., Hyllner, J., & 
Sartipy, P. (2008). Human embryonic stem cells: current 
technologies and emerging industrial applications. Crit Rev Oncol 
Hematol, 65(1), 54-80. doi: S1040-8428(07)00136-9 [pii] 
10.1016/j.critrevonc.2007.06.012 
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C. P., Harris, C. 
P., Waknitz, M. A., . . . Thomson, J. A. (2000). Clonally derived 
human embryonic stem cell lines maintain pluripotency and 
proliferative potential for prolonged periods of culture. Dev Biol, 
227(2), 271-278. doi: 10.1006/dbio.2000.9912 
S0012-1606(00)99912-3 [pii] 
Aravalli, R. N., Cressman, E. N., & Steer, C. J. (2012). Hepatic 
differentiation of porcine induced pluripotent stem cells in vitro. Vet 
J, 194(3), 369-374. doi: 10.1016/j.tvjl.2012.05.013 
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N., & 
Lovell-Badge, R. (2003). Multipotent cell lineages in early mouse 
development depend on SOX2 function. Genes Dev, 17(1), 126-
140. doi: 10.1101/gad.224503 
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabe-
Heider, F., Walsh, S., . . . Frisen, J. (2009). Evidence for 
cardiomyocyte renewal in humans. Science, 324(5923), 98-102. 
doi: 10.1126/science.1164680 
Blau, H. M., & Rossi, F. M. (1999). Tet B or not tet B: advances in 
tetracycline-inducible gene expression. Proc Natl Acad Sci U S A, 
96(3), 797-799.  
Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., 
Wernig, M., Suh, H., & Jaenisch, R. (2008). Sequential expression 
of pluripotency markers during direct reprogramming of mouse 
 97 
somatic cells. Cell Stem Cell, 2(2), 151-159. doi: 
10.1016/j.stem.2008.01.004 
Brevini, T. A., Antonini, S., Cillo, F., Crestan, M., & Gandolfi, F. 
(2007). Porcine embryonic stem cells: Facts, challenges and 
hopes. Theriogenology, 68 Suppl 1, S206-213. doi: 
10.1016/j.theriogenology.2007.05.043 
Brook, F. A., & Gardner, R. L. (1997). The origin and efficient 
derivation of embryonic stem cells in the mouse. Proc Natl Acad 
Sci U S A, 94(11), 5709-5712.  
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., 
Tweedie, S., & Smith, A. (2003). Functional expression cloning of 
Nanog, a pluripotency sustaining factor in embryonic stem cells. 
Cell, 113(5), 643-655. doi: S0092867403003921 [pii] 
Chen, J., Lu, Z., Cheng, D., Peng, S., & Wang, H. (2011). Isolation 
and characterization of porcine amniotic fluid-derived multipotent 
stem cells. PLoS One, 6(5), e19964. doi: 
10.1371/journal.pone.0019964 
Cheng, D., Guo, Y., Li, Z., Liu, Y., Gao, X., Gao, Y., . . . Wang, H. 
(2012). Porcine induced pluripotent stem cells require LIF and 
maintain their developmental potential in early stage of embryos. 
PLoS One, 7(12), e51778. doi: 10.1371/journal.pone.0051778 
Cheng, D., Li, Z., Liu, Y., Gao, Y., & Wang, H. (2012). Kinetic 
analysis of porcine fibroblast reprogramming toward pluripotency 
by defined factors. Cell Reprogram, 14(4), 312-323. doi: 
10.1089/cell.2012.0025 
Dang, D. T., Pevsner, J., & Yang, V. W. (2000). The biology of the 
mammalian Kruppel-like family of transcription factors. Int J 
Biochem Cell Biol, 32(11-12), 1103-1121. doi: S1357-
2725(00)00059-5 [pii] 
 98 
Doyon, Y., & Cote, J. (2004). The highly conserved and 
multifunctional NuA4 HAT complex. Curr Opin Genet Dev, 14(2), 
147-154. doi: 10.1016/j.gde.2004.02.009 
Dvash, T., & Benvenisty, N. (2004). Human embryonic stem cells 
as a model for early human development. Best Pract Res Clin 
Obstet Gynaecol, 18(6), 929-940. doi: 
10.1016/j.bpobgyn.2004.06.005 
Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of 
pluripotential cells from mouse embryos. Nature, 292(5819), 154-
156.  
Ezashi, T., Telugu, B. P., Alexenko, A. P., Sachdev, S., Sinha, S., 
& Roberts, R. M. (2009). Derivation of induced pluripotent stem 
cells from pig somatic cells. Proc Natl Acad Sci U S A, 106(27), 
10993-10998. doi: 10.1073/pnas.0905284106 
Ezashi, T., Telugu, B. P., & Roberts, R. M. (2012). Induced 
pluripotent stem cells from pigs and other ungulate species: an 
alternative to embryonic stem cells? Reprod Domest Anim, 47 
Suppl 4, 92-97. doi: 10.1111/j.1439-0531.2012.02061.x 
Fujishiro, S. H., Nakano, K., Mizukami, Y., Azami, T., Arai, Y., 
Matsunari, H., . . . Hanazono, Y. (2013). Generation of naive-like 
porcine-induced pluripotent stem cells capable of contributing to 
embryonic and fetal development. Stem Cells Dev, 22(3), 473-482. 
doi: 10.1089/scd.2012.0173 
Gao, Y., Guo, Y., Duan, A., Cheng, D., Zhang, S., & Wang, H. 
(2013). Optimization of Culture Conditions for Maintaining Porcine 
Induced Pluripotent Stem Cells. DNA Cell Biol. doi: 
10.1089/dna.2013.2095 
Gao, Y., Hyttel, P., & Hall, V. J. (2011). Dynamic changes in 
epigenetic marks and gene expression during porcine epiblast 
specification. Cell Reprogram, 13(4), 345-360. doi: 
10.1089/cell.2010.0110 
 99 
Gonzalez, F., Boue, S., & Izpisua Belmonte, J. C. (2011). Methods 
for making induced pluripotent stem cells: reprogramming a la 
carte. Nat Rev Genet, 12(4), 231-242. doi: 10.1038/nrg2937 
Graichen, R., Xu, X., Braam, S. R., Balakrishnan, T., Norfiza, S., 
Sieh, S., . . . Davidson, B. P. (2008). Enhanced cardiomyogenesis 
of human embryonic stem cells by a small molecular inhibitor of 
p38 MAPK. Differentiation, 76(4), 357-370. doi: 10.1111/j.1432-
0436.2007.00236.x 
Hall, V. J., Christensen, J., Gao, Y., Schmidt, M. H., & Hyttel, P. 
(2009). Porcine pluripotency cell signaling develops from the inner 
cell mass to the epiblast during early development. Dev Dyn, 
238(8), 2014-2024. doi: 10.1002/dvdy.22027 
Hall, V. J., Kristensen, M., Rasmussen, M. A., Ujhelly, O., Dinnyes, 
A., & Hyttel, P. (2012). Temporal repression of endogenous 
pluripotency genes during reprogramming of porcine induced 
pluripotent stem cells. Cell Reprogram, 14(3), 204-216. doi: 
10.1089/cell.2011.0089 
Hanna, L. A., Foreman, R. K., Tarasenko, I. A., Kessler, D. S., & 
Labosky, P. A. (2002). Requirement for Foxd3 in maintaining 
pluripotent cells of the early mouse embryo. Genes Dev, 16(20), 
2650-2661. doi: 10.1101/gad.1020502 
Harley, V. R., Lovell-Badge, R., & Goodfellow, P. N. (1994). 
Definition of a consensus DNA binding site for SRY. Nucleic Acids 
Res, 22(8), 1500-1501.  
Hay, D. C., Sutherland, L., Clark, J., & Burdon, T. (2004). Oct-4 
knockdown induces similar patterns of endoderm and trophoblast 
differentiation markers in human and mouse embryonic stem cells. 
Stem Cells, 22(2), 225-235.  
Hilbert, S. L., & Ferrans, V. J. (1992). Porcine aortic valve 
bioprostheses: morphologic and functional considerations. J Long 
Term Eff Med Implants, 2(2-3), 99-112.  
 100 
Hombria, J. C., & Lovegrove, B. (2003). Beyond homeosis--HOX 
function in morphogenesis and organogenesis. Differentiation, 
71(8), 461-476. doi: 07108004 [pii] 
Hori, Y., Rulifson, I. C., Tsai, B. C., Heit, J. J., Cahoy, J. D., & Kim, 
S. K. (2002). Growth inhibitors promote differentiation of insulin-
producing tissue from embryonic stem cells. Proc Natl Acad Sci U 
S A, 99(25), 16105-16110. doi: 10.1073/pnas.252618999 
252618999 [pii] 
Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., . . . Deng, H. 
(2013). Pluripotent stem cells induced from mouse somatic cells by 
small-molecule compounds. Science, 341(6146), 651-654. doi: 
10.1126/science.1239278 
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, 
O., Amit, M., . . . Benvenisty, N. (2000). Differentiation of human 
embryonic stem cells into embryoid bodies compromising the three 
embryonic germ layers. Mol Med, 6(2), 88-95.  
Kaczynski, J., Cook, T., & Urrutia, R. (2003). Sp1- and Kruppel-like 
transcription factors. Genome Biol, 4(2), 206.  
Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., 
Gepstein, A., . . . Gepstein, L. (2001). Human embryonic stem cells 
can differentiate into myocytes with structural and functional 
properties of cardiomyocytes. J Clin Invest, 108(3), 407-414. doi: 
10.1172/JCI12131 
Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A., Velasco, I., 
Gavin, D., Lumelsky, N., . . . McKay, R. (2002). Dopamine neurons 
derived from embryonic stem cells function in an animal model of 
Parkinson's disease. Nature, 418(6893), 50-56. doi: 
10.1038/nature00900 
nature00900 [pii] 
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., 
Fugate, J. A., Dupras, S. K., . . . Murry, C. E. (2007). 
 101 
Cardiomyocytes derived from human embryonic stem cells in pro-
survival factors enhance function of infarcted rat hearts. Nat 
Biotechnol, 25(9), 1015-1024. doi: 10.1038/nbt1327 
Lin, C. H., Jackson, A. L., Guo, J., Linsley, P. S., & Eisenman, R. 
N. (2009). Myc-regulated microRNAs attenuate embryonic stem 
cell differentiation. EMBO J, 28(20), 3157-3170. doi: 
10.1038/emboj.2009.254 
Liu, K., Ji, G., Mao, J., Liu, M., Wang, L., Chen, C., & Liu, L. 
(2012). Generation of porcine-induced pluripotent stem cells by 
using OCT4 and KLF4 porcine factors. Cell Reprogram, 14(6), 505-
513. doi: 10.1089/cell.2012.0047 
Loh, Y. H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., . 
. . Ng, H. H. (2006). The Oct4 and Nanog transcription network 
regulates pluripotency in mouse embryonic stem cells. Nat Genet, 
38(4), 431-440. doi: ng1760 [pii] 
10.1038/ng1760 
Masuda, S., Wu, J., Hishida, T., Pandian, G. N., Sugiyama, H., & 
Izpisua Belmonte, J. C. (2013). Chemically induced pluripotent 
stem cells (CiPSCs): a transgene-free approach. J Mol Cell Biol, 
5(5), 354-355. doi: 10.1093/jmcb/mjt034 
Meissner, A., Wernig, M., & Jaenisch, R. (2007). Direct 
reprogramming of genetically unmodified fibroblasts into pluripotent 
stem cells. Nat Biotechnol, 25(10), 1177-1181. doi: nbt1335 [pii] 
10.1038/nbt1335 
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., 
Takahashi, K., . . . Yamanaka, S. (2003). The homeoprotein Nanog 
is required for maintenance of pluripotency in mouse epiblast and 
ES cells. Cell, 113(5), 631-642. doi: S0092867403003933 [pii] 
Montserrat, N., Bahima, E. G., Batlle, L., Hafner, S., Rodrigues, A. 
M., Gonzalez, F., & Izpisua Belmonte, J. C. (2011). Generation of 
 102 
pig iPS cells: a model for cell therapy. J Cardiovasc Transl Res, 
4(2), 121-130. doi: 10.1007/s12265-010-9233-3 
Montserrat, N., de Onate, L., Garreta, E., Gonzalez, F., Adamo, A., 
Eguizabal, C., . . . Izpisua Belmonte, J. C. (2012). Generation of 
feeder-free pig induced pluripotent stem cells without Pou5f1. Cell 
Transplant, 21(5), 815-825. doi: 10.3727/096368911X601019 
Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, 
R., van den Brink, S., Hassink, R., . . . Tertoolen, L. (2003). 
Differentiation of human embryonic stem cells to cardiomyocytes: 
role of coculture with visceral endoderm-like cells. Circulation, 
107(21), 2733-2740. doi: 10.1161/01.CIR.0000068356.38592.68 
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, 
T., Aoi, T., . . . Yamanaka, S. (2008). Generation of induced 
pluripotent stem cells without Myc from mouse and human 
fibroblasts. Nat Biotechnol, 26(1), 101-106. doi: 10.1038/nbt1374 
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-
Nebenius, D., Chambers, I., . . . Smith, A. (1998). Formation of 
pluripotent stem cells in the mammalian embryo depends on the 
POU transcription factor Oct4. Cell, 95(3), 379-391. doi: S0092-
8674(00)81769-9 [pii] 
Niwa, H., Burdon, T., Chambers, I., & Smith, A. (1998). Self-
renewal of pluripotent embryonic stem cells is mediated via 
activation of STAT3. Genes Dev, 12(13), 2048-2060.  
Niwa, H., Miyazaki, J., & Smith, A. G. (2000). Quantitative 
expression of Oct-3/4 defines differentiation, dedifferentiation or 
self-renewal of ES cells. Nat Genet, 24(4), 372-376. doi: 
10.1038/74199 
Notarianni, E., Laurie, S., Moor, R. M., & Evans, M. J. (1990). 
Maintenance and differentiation in culture of pluripotential 
embryonic cell lines from pig blastocysts. J Reprod Fertil Suppl, 41, 
51-56.  
 103 
Odorico, J. S., Kaufman, D. S., & Thomson, J. A. (2001). 
Multilineage differentiation from human embryonic stem cell lines. 
Stem Cells, 19(3), 193-204. doi: 10.1634/stemcells.19-3-193 
Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of 
germline-competent induced pluripotent stem cells. Nature, 
448(7151), 313-317. doi: 10.1038/nature05934 
Pan, G. J., Chang, Z. Y., Scholer, H. R., & Pei, D. (2002). Stem cell 
pluripotency and transcription factor Oct4. Cell Res, 12(5-6), 321-
329. doi: 10.1038/sj.cr.7290134 
Pasumarthi, K. B., & Field, L. J. (2002). Cardiomyocyte cell cycle 
regulation. Circ Res, 90(10), 1044-1054.  
Pesce, M., & Scholer, H. R. (2001). Oct-4: gatekeeper in the 
beginnings of mammalian development. Stem Cells, 19(4), 271-
278.  
Pevny, L. H., & Lovell-Badge, R. (1997). Sox genes find their feet. 
Curr Opin Genet Dev, 7(3), 338-344. doi: S0959-437X(97)80147-5 
[pii] 
Piedrahita, J. A., Anderson, G. B., & Bondurant, R. H. (1990). On 
the isolation of embryonic stem cells: Comparative behavior of 
murine, porcine and ovine embryos. Theriogenology, 34(5), 879-
901.  
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & 
Melton, D. A. (2002). "Stemness": transcriptional profiling of 
embryonic and adult stem cells. Science, 298(5593), 597-600. doi: 
10.1126/science.1072530 
1072530 [pii] 
Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., & Bongso, 
A. (2000). Embryonic stem cell lines from human blastocysts: 
somatic differentiation in vitro. Nat Biotechnol, 18(4), 399-404. doi: 
10.1038/74447 
 104 
Rodriguez, A., Contreras, D. A., & Alberio, R. (2013). Isolation and 
culture of pig epiblast stem cells. Methods Mol Biol, 1074, 97-110. 
doi: 10.1007/978-1-62703-628-3_8 
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. 
D., Brown, T. M., . . . Stroke Statistics, Subcommittee. (2011). 
Heart disease and stroke statistics--2011 update: a report from the 
American Heart Association. Circulation, 123(4), e18-e209. doi: 
10.1161/CIR.0b013e3182009701 
Rossant, J. (2007). Stem cells and lineage development in the 
mammalian blastocyst. Reprod Fertil Dev, 19(1), 111-118.  
Ruan, W., Han, J., Li, P., Cao, S., An, Y., Lim, B., & Li, N. (2011). A 
novel strategy to derive iPS cells from porcine fibroblasts. Sci 
China Life Sci, 54(6), 553-559. doi: 10.1007/s11427-011-4179-5 
Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griffiths, B. 
L., Smith, M. J., . . . Goodfellow, P. N. (1990). A gene from the 
human sex-determining region encodes a protein with homology to 
a conserved DNA-binding motif. Nature, 346(6281), 240-244. doi: 
10.1038/346240a0 
Symons, J. A., Alcami, A., & Smith, G. L. (1995). Vaccinia virus 
encodes a soluble type I interferon receptor of novel structure and 
broad species specificity. Cell, 81(4), 551-560.  
Synnergren, J., Akesson, K., Dahlenborg, K., Vidarsson, H., 
Ameen, C., Steel, D., . . . Sartipy, P. (2008). Molecular signature of 
cardiomyocyte clusters derived from human embryonic stem cells. 
Stem Cells. doi: 2007-1033 [pii] 
10.1634/stemcells.2007-1033 
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., 
Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem 
cells from adult human fibroblasts by defined factors. Cell, 131(5), 
861-872. doi: 10.1016/j.cell.2007.11.019 
 105 
Tam, P. P., & Behringer, R. R. (1997). Mouse gastrulation: the 
formation of a mammalian body plan. Mech Dev, 68(1-2), 3-25.  
Tanabe, K., Nakamura, M., Narita, M., Takahashi, K., & 
Yamanaka, S. (2013). Maturation, not initiation, is the major 
roadblock during reprogramming toward pluripotency from human 
fibroblasts. Proc Natl Acad Sci U S A, 110(30), 12172-12179. doi: 
10.1073/pnas.1310291110 
Telugu, B. P., Ezashi, T., & Roberts, R. M. (2010). Porcine induced 
pluripotent stem cells analogous to naive and primed embryonic 
stem cells of the mouse. Int J Dev Biol, 54(11-12), 1703-1711. doi: 
10.1387/ijdb.103200bt 
Telugu, B. P., Ezashi, T., Sinha, S., Alexenko, A. P., Spate, L., 
Prather, R. S., & Roberts, R. M. (2011). Leukemia inhibitory factor 
(LIF)-dependent, pluripotent stem cells established from inner cell 
mass of porcine embryos. J Biol Chem, 286(33), 28948-28953. doi: 
10.1074/jbc.M111.229468 
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., 
Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998). Embryonic 
stem cell lines derived from human blastocysts. Science, 
282(5391), 1145-1147.  
Vejlsted, M., Du, Y., Vajta, G., & Maddox-Hyttel, P. (2006). Post-
hatching development of the porcine and bovine embryo--defining 
criteria for expected development in vivo and in vitro. 
Theriogenology, 65(1), 153-165. doi: 
10.1016/j.theriogenology.2005.09.021 
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y. H., Li, H., Lau, F., . . . 
Rossi, D. J. (2010). Highly efficient reprogramming to pluripotency 
and directed differentiation of human cells with synthetic modified 
mRNA. Cell Stem Cell, 7(5), 618-630. doi: 
10.1016/j.stem.2010.08.012 
West, F. D., Terlouw, S. L., Kwon, D. J., Mumaw, J. L., Dhara, S. 
K., Hasneen, K., . . . Stice, S. L. (2010). Porcine induced 
 106 
pluripotent stem cells produce chimeric offspring. Stem Cells Dev, 
19(8), 1211-1220. doi: 10.1089/scd.2009.0458 
Wianny, F., Perreau, C., & Hochereau de Reviers, M. T. (1997). 
Proliferation and differentiation of porcine inner cell mass and 
epiblast in vitro. Biol Reprod, 57(4), 756-764.  
Wu, Z., Chen, J., Ren, J., Bao, L., Liao, J., Cui, C., . . . Xiao, L. 
(2009). Generation of pig induced pluripotent stem cells with a 
drug-inducible system. J Mol Cell Biol, 1(1), 46-54. doi: 
10.1093/jmcb/mjp003 
Yamanaka, S. (2007). Strategies and new developments in the 
generation of patient-specific pluripotent stem cells. Cell Stem Cell, 
1(1), 39-49. doi: 10.1016/j.stem.2007.05.012 
Yang, J. Y., Mumaw, J. L., Liu, Y., Stice, S. L., & West, F. D. 
(2013). SSEA4-positive pig induced pluripotent stem cells are 
primed for differentiation into neural cells. Cell Transplant, 22(6), 
945-959. doi: 10.3727/096368912X657279 
Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., & Jiang, Y. (2011). 
Efficient feeder-free episomal reprogramming with small molecules. 
PLoS One, 6(3), e17557. doi: 10.1371/journal.pone.0017557 
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., 
Frane, J. L., Tian, S., . . . Thomson, J. A. (2007). Induced 
pluripotent stem cell lines derived from human somatic cells. 
Science, 318(5858), 1917-1920. doi: 10.1126/science.1151526 
 
